Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
The blood vessels which supply and drain the RETINA.
A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)
A pathological process consisting of the formation of new blood vessels in the CHOROID.
New blood vessels originating from the corneal veins and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.
The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced.
A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions.
Retinal diseases refer to a diverse group of vision-threatening disorders that affect the retina's structure and function, including age-related macular degeneration, diabetic retinopathy, retinal detachment, retinitis pigmentosa, and macular edema, among others.
The development of new BLOOD VESSELS during the restoration of BLOOD CIRCULATION during the healing process.
Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature.
The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent.
An abnormal increase in the amount of oxygen in the tissues and organs.
A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
The transparent, semigelatinous substance that fills the cavity behind the CRYSTALLINE LENS of the EYE and in front of the RETINA. It is contained in a thin hyaloid membrane and forms about four fifths of the optic globe.
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
Agents and endogenous substances that antagonize or inhibit the development of new blood vessels.
An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration.
Abnormal intravascular leukocyte aggregation and clumping often seen in leukemia patients. The brain and lungs are the two most commonly affected organs. This acute syndrome requires aggressive cytoreductive modalities including chemotherapy and/or leukophoresis. It is differentiated from LEUKEMIC INFILTRATION which is a neoplastic process where leukemic cells invade organs.
Refers to animals in the period of time just after birth.
The administration of substances into the VITREOUS BODY of the eye with a hypodermic syringe.
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
A family of angiogenic proteins that are closely-related to VASCULAR ENDOTHELIAL GROWTH FACTOR A. They play an important role in the growth and differentiation of vascular as well as lymphatic endothelial cells.
A family of serine proteinase inhibitors which are similar in amino acid sequence and mechanism of inhibition, but differ in their specificity toward proteolytic enzymes. This family includes alpha 1-antitrypsin, angiotensinogen, ovalbumin, antiplasmin, alpha 1-antichymotrypsin, thyroxine-binding protein, complement 1 inactivators, antithrombin III, heparin cofactor II, plasminogen inactivators, gene Y protein, placental plasminogen activator inhibitor, and barley Z protein. Some members of the serpin family may be substrates rather than inhibitors of SERINE ENDOPEPTIDASES, and some serpins occur in plants where their function is not known.
These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesize DNA. The factors are related to both the basic and acidic FIBROBLAST GROWTH FACTORS but have different amino acid sequences.
Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity.
The coagulation of tissue by an intense beam of light, including laser (LASER COAGULATION). In the eye it is used in the treatment of retinal detachments, retinal holes, aneurysms, hemorrhages, and malignant and benign neoplasms. (Dictionary of Visual Science, 3d ed)
Introduction of substances into the body using a needle and syringe.
The concave interior of the eye, consisting of the retina, the choroid, the sclera, the optic disk, and blood vessels, seen by means of the ophthalmoscope. (Cline et al., Dictionary of Visual Science, 4th ed)
A 200-230-kDa tyrosine kinase receptor for vascular endothelial growth factors found primarily in endothelial and hematopoietic cells and their precursors. VEGFR-2 is important for vascular and hematopoietic development, and mediates almost all endothelial cell responses to VEGF.
A specialized transport barrier, in the EYE, formed by the retinal pigment EPITHELIUM, and the ENDOTHELIUM of the BLOOD VESSELS of the RETINA. TIGHT JUNCTIONS joining adjacent cells keep the barrier between cells continuous.
Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer.
Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components.
A form of fluorescent antibody technique commonly used to detect serum antibodies and immune complexes in tissues and microorganisms in specimens from patients with infectious diseases. The technique involves formation of an antigen-antibody complex which is labeled with fluorescein-conjugated anti-immunoglobulin antibody. (From Bennington, Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)
Relatively complete absence of oxygen in one or more tissues.
The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.
A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.
'Eye proteins' are structural or functional proteins, such as crystallins, opsins, and collagens, located in various parts of the eye, including the cornea, lens, retina, and aqueous humor, that contribute to maintaining transparency, refractive power, phototransduction, and overall integrity of the visual system.
Hemorrhage into the VITREOUS BODY.
Factors which enhance the growth potentialities of sensory and sympathetic nerve cells.
The minute vessels that connect the arterioles and venules.
A plant genus of the family APIACEAE.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall.
A 180-kDa VEGF receptor found primarily in endothelial cells that is essential for vasculogenesis and vascular maintenance. It is also known as Flt-1 (fms-like tyrosine kinase receptor-1). A soluble, alternatively spliced isoform of the receptor may serve as a binding protein that regulates the availability of various ligands for VEGF receptor binding and signal transduction.
Inbreed BN (Brown Norway) rats are a strain of laboratory rats that are specifically bred for research purposes, characterized by their uniform genetic makeup and susceptibility to various diseases, which makes them ideal models for studying human physiology and pathophysiology.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
An angiopoietin that is closely related to ANGIOPOIETIN-1. It binds to the TIE-2 RECEPTOR without receptor stimulation and antagonizes the effect of ANGIOPOIETIN-1. However its antagonistic effect may be limited to cell receptors that occur within the vasculature. Angiopoietin-2 may therefore play a role in down-regulation of BLOOD VESSEL branching and sprouting.
A TIE receptor tyrosine kinase that is found almost exclusively on ENDOTHELIAL CELLS. It is required for both normal embryonic vascular development (NEOVASCULARIZATION, PHYSIOLOGIC) and tumor angiogenesis (NEOVASCULARIZATION, PATHOLOGIC).
An infant during the first month after birth.
A family of closely related RECEPTOR PROTEIN-TYROSINE KINASES that bind vascular endothelial growth factors. They share a cluster of seven extracellular Ig-like domains which are important for ligand binding. They are highly expressed in vascular endothelial cells and are critical for the physiological and pathological growth, development and maintenance of blood and lymphatic vessels.
Endothelial cells that line venous vessels of the UMBILICAL CORD.
A 20-carbon dibenz(de,kl)anthracene that can be viewed as a naphthalene fused to a phenalene or as dinaphthalene. It is used as fluorescent lipid probe in the cytochemistry of membranes and is a polycyclic hydrocarbon pollutant in soil and water. Derivatives may be carcinogenic.
The thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA.
Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
Inflammation of the RETINA. It is rarely limited to the retina, but is commonly associated with diseases of the choroid (CHORIORETINITIS) and of the OPTIC DISK (neuroretinitis).
An in situ method for detecting areas of DNA which are nicked during APOPTOSIS. Terminal deoxynucleotidyl transferase is used to add labeled dUTP, in a template-independent manner, to the 3 prime OH ends of either single- or double-stranded DNA. The terminal deoxynucleotidyl transferase nick end labeling, or TUNEL, assay labels apoptosis on a single-cell level, making it more sensitive than agarose gel electrophoresis for analysis of DNA FRAGMENTATION.
The finer blood vessels of the vasculature that are generally less than 100 microns in internal diameter.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes.
The use of green light-producing LASERS to stop bleeding. The green light is selectively absorbed by HEMOGLOBIN, thus triggering BLOOD COAGULATION.
The transparent anterior portion of the fibrous coat of the eye consisting of five layers: stratified squamous CORNEAL EPITHELIUM; BOWMAN MEMBRANE; CORNEAL STROMA; DESCEMET MEMBRANE; and mesenchymal CORNEAL ENDOTHELIUM. It serves as the first refracting medium of the eye. It is structurally continuous with the SCLERA, avascular, receiving its nourishment by permeation through spaces between the lamellae, and is innervated by the ophthalmic division of the TRIGEMINAL NERVE via the ciliary nerves and those of the surrounding conjunctiva which together form plexuses. (Cline et al., Dictionary of Visual Science, 4th ed)
Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
Nutrient blood vessels which supply the walls of large arteries or veins.
The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement.
A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins.
An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
Injury to any part of the eye by extreme heat, chemical agents, or ultraviolet radiation.
Either of two extremities of four-footed non-primate land animals. It usually consists of a FEMUR; TIBIA; and FIBULA; tarsals; METATARSALS; and TOES. (From Storer et al., General Zoology, 6th ed, p73)
Regulatory proteins and peptides that are signaling molecules involved in the process of PARACRINE COMMUNICATION. They are generally considered factors that are expressed by one cell and are responded to by receptors on another nearby cell. They are distinguished from HORMONES in that their actions are local rather than distal.
Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain.
The administration of substances into the eye with a hypodermic syringe.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
'Chemical burns' is a medical term that refers to injuries resulting from skin or eye contact with harmful substances, such as acids, alkalis, or irritants, which can cause damage ranging from mild irritation to severe necrosis and scarring.
Small double-stranded, non-protein coding RNAs (21-31 nucleotides) involved in GENE SILENCING functions, especially RNA INTERFERENCE (RNAi). Endogenously, siRNAs are generated from dsRNAs (RNA, DOUBLE-STRANDED) by the same ribonuclease, Dicer, that generates miRNAs (MICRORNAS). The perfect match of the siRNAs' antisense strand to their target RNAs mediates RNAi by siRNA-guided RNA cleavage. siRNAs fall into different classes including trans-acting siRNA (tasiRNA), repeat-associated RNA (rasiRNA), small-scan RNA (scnRNA), and Piwi protein-interacting RNA (piRNA) and have different specific gene silencing functions.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.
Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.
The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION.
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Agents that induce or stimulate PHYSIOLOGIC ANGIOGENESIS or PATHOLOGIC ANGIOGENESIS.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.

Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. (1/515)

Thrombospondin-1 is an extracellular matrix protein that inhibits endothelial cell proliferation, migration, and angiogenesis. This study was performed to investigate the role of thrombospondin-1 in ischemic retinal neovascularization. In a murine model of retinal neovascularization, thrombospondin-1 mRNA was increased from postnatal day 13 (P13), with a threefold peak response observed on P15, corresponding to the time of development of retinal neovascularization. Prominent expression of thrombospondin-1 was observed in neovascular cells, specifically, cells adjacent to the area of nonperfusion. It has been suggested that vascular endothelial growth factor (VEGF) plays a major role in ischemia-induced retinal neovascularization of this model, so we studied the effects of VEGF on thrombospondin-1 expression. In bovine retinal microcapillary endothelial cells, VEGF induced a biphasic response of thrombospondin-1 expression; VEGF decreased thrombospondin-1 mRNA 0.41-fold after 4 hours, whereas it increased, with a threefold peak response, after 24 hours. VEGF-induced endothelial cell proliferation was completely inhibited by exogenous thrombospondin-1 and increased by 37.5% with anti-thrombospondin-1 antibody. The present findings suggest that, in the ischemic retina, retinal neovascular cells increase thrombospondin-1 expression, and VEGF may stimulate endogenous thrombospondin-1 induction, which inhibits endothelial cell growth. VEGF-mediated thrombospondin-1 induction in ischemia-induced angiogenesis may be a negative feedback mechanism.  (+info)

Metabolic acidosis-induced retinopathy in the neonatal rat. (2/515)

PURPOSE: Carbon dioxide (CO2)-induced retinopathy (CDIR) in the neonatal rat, analogous to human retinopathy of prematurity (ROP), was previously described by our group. In this model, it is possible that CO2-associated acidosis provides a biochemical mechanism for CDIR. Therefore, the effect of pure metabolic acidosis on the developing retinal vasculature of the neonatal rat was investigated. METHODS: A preliminary study of arterial blood pH was performed to confirm acidosis in our model. In neonatal rats with preplaced left carotid artery catheters, acute blood gas samples were taken 1 to 24 hours after gavage with either NH4Cl 1 millimole/100 g body weight or saline. In the subsequent formal retinopathy study, 150 newborn Sprague-Dawley rats were raised in litters of 25 and randomly assigned to be gavaged twice daily with either NH4Cl 1 millimole/100 g body weight (n = 75) or saline (n = 75) from day 2 to day 7. After 5 days of recovery, rats were killed, and retinal vasculature was assessed using fluorescein perfusion and ADPase staining techniques. RESULTS: In the preliminary pH study, the minimum pH after NH4Cl gavage was 7.10+/-0.10 at 3 hours (versus 7.37+/-0.03 in controls, mean +/- SD, P < 0.01). In the formal retinopathy study, preretinal neovascularization occurred in 36% of acidotic rats versus 5% of controls (P < 0.001). Acidotic rats showed growth retardation (final weight 16.5+/-3.0 g versus 20.2+/-2.6 g, P < 0.001). The ratio of vascularized to total retinal area was smaller in acidotic rats (94%+/-4% versus 96%+/-2%, P < 0.001). CONCLUSIONS: Metabolic acidosis alone induces neovascularization similar to ROP in the neonatal rat. This suggests a possible biochemical mechanism by which high levels of CO2 induce neovascularization and supports the suggestion that acidosis may be an independent risk factor for ROP.  (+info)

Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. (3/515)

PURPOSE: Retinal neovascularization is one of the leading causes of blindness. A crucial event in this process is the remodeling and penetration of the capillary basement membrane by migrating endothelial cells. This process requires proteolysis of basement membrane components by a variety of proteinases. The objective of the present study was to determine the expression of proteinases in human retinal tissues showing active neovascularization. METHODS: Epiretinal neovascular membranes surgically removed from patients with proliferative diabetic retinopathy were analyzed by zymography, and the types and amounts of proteinases present in the tissues were determined. Retinas from nondiabetic donor eyes served as control specimens. RESULTS: Both the high- (54 kDa) and low- (33 kDa) molecular-weight forms of urokinase were present at significantly higher levels in neovascular membranes than in normal retinas. The pro forms of the matrix metalloproteinases (MMP) MMP-2 and MMP-9 were significantly elevated in the neovascular membranes in comparison with levels in normal retinas. In addition, the active forms of these enzymes were present in the membranes, whereas there was no detectable level of the active forms in normal retinas. CONCLUSIONS: Human diabetic neovascular membranes contain high levels of urokinase and MMP. The increased activity of proteinases in the final common pathway of retinal neovascularization indicates that inhibition of these enzymes may be a useful therapeutic target as an alternative approach in the management of proliferative retinopathies.  (+info)

Radiotherapy for isolated occult subfoveal neovascularisation in age related macular degeneration: a pilot study. (4/515)

BACKGROUND/AIMS: Teletherapy has been proposed as a possible treatment for choroidal neovascular membranes (CNV), secondary to age related macular degeneration (AMD) not amenable to laser photocoagulation. The aim of this prospective study has been to investigate the effect of teletherapy on isolated occult choroidal neovascular membranes of subfoveal location. METHODS: 28 AMD patients presenting with retrofoveal isolated occult CNV demonstrated by fluorescein angiography were treated by external beam radiation. A complete ophthalmological examination, fluorescein angiography, and indocyanine green angiography (ICG) were performed within 15 days before treatment and repeated at follow up. A total dose of 16 Gy was applied in four sessions of 4 Gy using a 4 MeV photon beam. Follow up ranged from 6 to 9 months (mean follow up 6.4 months). RESULTS: Visual acuity was found to be stable in 68% of the cases. The decrease in visual acuity was of 3-6 lines in 18% and of more than 6 lines in 10% of the eyes at last examination. On fluorescein angiography the size of the lesion area was found to be stable in 67%, decreased in 13%, and increased in 20% of the cases. On ICG angiography the size of the CNV was stable in 93% and increased in 7% of the cases. All the eyes experiencing a visual acuity decrease showed either no change or an increase in size of the membrane on fluorescein angiography and/or on ICG. CONCLUSION: According to this study with strict inclusion criteria, external beam radiotherapy seems to have a beneficial effect on the evolution of isolated occult subfoveal CNV.  (+info)

Suppression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbamate in mice. (5/515)

PURPOSE: To evaluate the effect of pyrrolidine dithiocarbamate (PDTC), an inhibitor of nuclear factor kappaB (NF-kappaB), on retinal neovascularization in a murine model of ischemic retinopathy. METHODS: One-week-old C57BL/6N mice were exposed to 75%+/-2% oxygen for 5 days and then were returned to room air to induce retinal neovascularization. After the return to room air, the left and right eyes were injected intravitreally with PDTC or a vehicle, respectively. Retinal neovascularization was examined by injecting fluorescein dextran and angiography after 5 days in room air and was quantitated histologically with a masked protocol. The effects of PDTC on NF-kappaB activation were evaluated by immunohistochemistry. To examine the toxicity of PDTC, the histologic change in the retina was examined by light and electron microscopy. RESULTS: Retinal neovascularization in the eye injected with PDTC by intravitreal methods was reduced in 100% of animals compared with that apparent in the vehicle-treated eye. The inhibitory effect was dose-dependent, with a maximal inhibition of 39% (P < 0.01) at a dose of 1 nmole. The immunostaining intensity for NF-KB in the retina was reduced by PDTC injections. No side effects by PDTC in the retina were observed by light and electron microscopy. CONCLUSIONS: NF-kappaB activation appears to be required for retinal angiogenesis, given that the administration of PDTC suppressed retinal neovascularization. PDTC may prove beneficial in the treatment of ischemic neovascular diseases such as diabetic retinopathy and retinal vein occlusion.  (+info)

Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. (6/515)

The most common cause of new blindness in young patients is retinal neovascularization, and in the elderly is choroidal neovascularization. Therefore, there has been a great deal of attention focused on the development of new treatments for these disease processes. Previous studies have demonstrated partial inhibition of retinal neovascularization in animal models using antagonists of vascular endothelial growth factor or other signaling molecules implicated in the angiogenesis cascade. These studies have indicated potential for drug treatment, but have left many questions unanswered. Is it possible to completely inhibit retinal neovascularization using drug treatment with a mode of administration that is feasible to use in patients? Do agents that inhibit retinal neovascularization have any effect on choroidal neovascularization? In this study, we demonstrate complete inhibition of retinal neovascularization in mice with oxygen-induced ischemic retinopathy by oral administration of a partially selective kinase inhibitor that blocks several members of the protein kinase C family, along with vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinases. The drug also blocks normal vascularization of the retina during development but has no identifiable adverse effects on mature retinal vessels. In addition, the kinase inhibitor causes dramatic inhibition of choroidal neovascularization in a laser-induced murine model. These data provide proof of concept that pharmacological treatment is a viable approach for therapy of both retinal and choroidal neovascularization.  (+info)

Angiogenic factors in human proliferative sickle cell retinopathy. (7/515)

BACKGROUND/AIMS: Preretinal neovascular formations called sea fans develop at the border of non-perfused peripheral retina in sickle cell retinopathy. Angiogenic factors which could contribute to their development, however, have not been examined previously. The objective of this study was to determine immunohistochemically if vascular endothelial growth factor (VEGF) or basic fibroblast growth factor (bFGF) were associated with sea fan formations. METHODS: Immunohistochemistry on cryosections was used to localise bFGF, VEGF, heparan sulphate proteoglycan, human serum albumin, collagens IV and II, and von Willebrand factor in tissue from five sickle cell and one control subject. RESULTS: The greatest immunoreactivity for VEGF and bFGF was in the feeder and preretinal vessels of sea fans (p<0.01). The most prominent reaction product was localised to vascular endothelial cells. In retinal vessels, VEGF and bFGF immunoreactivities were greater in sickle cell subjects (both proliferative and non-proliferative) than in the control subject (p<0.01 and p<0.02 respectively). In the sickle cell retina, no angiogenic factor immunoreactivity was detected in non-perfused periphery and there was no significant difference in bFGF or VEGF immunoreactivity between perfused retina and the border of perfused and non-perfused areas. CONCLUSION: Our results demonstrate for the first time that VEGF and bFGF are associated with sea fan formations in sickle cell retinopathy. Both factors may function in an autocrine manner because immunoreactivity for these factors was greater within the neovascularisation than in adjacent retina.  (+info)

N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration. (8/515)

PURPOSE: To investigate whether glycoxidation products and the receptor for advanced glycation end products (RAGE) are present and colocalize in subfoveal membranes of patients with age-related macular degeneration (ARMD). METHODS: Surgically removed subfoveal fibrovascular membranes from 12 patients, 11 related to ARMD and 1 to an idiopathic membrane, were analyzed for the presence of the glycoxidation product N(epsilon)-(carboxymethyl)lysin (CML), one of the receptors for advanced glycation end products, RAGE, and the activation of NFkB, using immunohistochemistry. RESULTS: CML-like immunoreactivity was found in all ARMD specimens examined adjacent or colocalized with RAGE, but not in the idiopathic membrane. RAGE immunoreactive material was found in CD68-positive cells and in the fibrous matrix. CD68-positive cells and surrounding areas stained for p50, the activated form of NFkB. CONCLUSIONS: These results indicate that glycoxidation products are present in subretinal membranes of patients with ARMD. The concomitant expression of RAGE in these membranes and the finding of activated NFkB is suggestive of an implication of glycoxidation product formation in the pathogenesis of the disease.  (+info)

Retinal neovascularization is a medical condition characterized by the growth of new, abnormal blood vessels on the surface of the retina, which is the light-sensitive tissue located at the back of the eye. This condition typically occurs in response to an insufficient supply of oxygen and nutrients to the retina, often due to damage or disease, such as diabetic retinopathy or retinal vein occlusion.

The new blood vessels that form during neovascularization are fragile and prone to leakage, which can cause fluid and protein to accumulate in the retina, leading to distorted vision, hemorrhages, and potentially blindness if left untreated. Retinal neovascularization is a serious eye condition that requires prompt medical attention and management to prevent further vision loss.

Retinal vessels refer to the blood vessels that are located in the retina, which is the light-sensitive tissue that lines the inner surface of the eye. The retina contains two types of blood vessels: arteries and veins.

The central retinal artery supplies oxygenated blood to the inner layers of the retina, while the central retinal vein drains deoxygenated blood from the retina. These vessels can be visualized during a routine eye examination using an ophthalmoscope, which allows healthcare professionals to assess their health and any potential abnormalities.

Retinal vessels are essential for maintaining the health and function of the retina, and any damage or changes to these vessels can affect vision and lead to various eye conditions such as diabetic retinopathy, retinal vein occlusion, and hypertensive retinopathy.

Retinopathy of Prematurity (ROP) is a potentially sight-threatening proliferative retinal vascular disorder that primarily affects prematurely born infants, particularly those with low birth weight and/or young gestational age. It is characterized by the abnormal growth and development of retinal blood vessels due to disturbances in the oxygen supply and metabolic demands during critical phases of fetal development.

The condition can be classified into various stages (1-5) based on its severity, with stages 4 and 5 being more severe forms that may lead to retinal detachment and blindness if left untreated. The pathogenesis of ROP involves an initial phase of vessel loss and regression in the central retina, followed by a secondary phase of abnormal neovascularization, which can cause fibrosis, traction, and ultimately, retinal detachment.

ROP is typically managed with a multidisciplinary approach involving ophthalmologists, neonatologists, and pediatricians. Treatment options include laser photocoagulation, cryotherapy, intravitreal anti-VEGF injections, or even surgical interventions to prevent retinal detachment and preserve vision. Regular screening examinations are crucial for early detection and timely management of ROP in at-risk infants.

Choroidal neovascularization (CNV) is a medical term that refers to the growth of new, abnormal blood vessels in the choroid layer of the eye, which is located between the retina and the sclera. This condition typically occurs as a complication of age-related macular degeneration (AMD), although it can also be caused by other eye diseases or injuries.

In CNV, the new blood vessels that grow into the choroid layer are fragile and can leak fluid or blood, which can cause distortion or damage to the retina, leading to vision loss. Symptoms of CNV may include blurred or distorted vision, a blind spot in the center of the visual field, or changes in color perception.

Treatment for CNV typically involves medications that are designed to stop the growth of new blood vessels, such as anti-VEGF drugs, which target a protein called vascular endothelial growth factor (VEGF) that is involved in the development of new blood vessels. Laser surgery or photodynamic therapy may also be used in some cases to destroy the abnormal blood vessels and prevent further vision loss.

Corneal neovascularization is a medical condition that refers to the growth of new, abnormal blood vessels in the cornea, which is the clear, dome-shaped surface at the front of the eye. The cornea typically receives its nutrients from tears and oxygen in the air, so it does not have its own blood vessels. However, when the cornea is damaged or inflamed, it may trigger the growth of new blood vessels from the surrounding tissue into the cornea to promote healing.

Corneal neovascularization can occur due to various eye conditions such as infection, injury, inflammation, degenerative diseases, or contact lens wear. Excessive growth of blood vessels in the cornea can interfere with vision, cause scarring, and increase the risk of corneal transplant rejection. Treatment for corneal neovascularization depends on the underlying cause and may include topical medications, surgery, or other therapies to reduce inflammation, prevent further growth of blood vessels, and preserve vision.

Vascular Endothelial Growth Factor A (VEGFA) is a specific isoform of the vascular endothelial growth factor (VEGF) family. It is a well-characterized signaling protein that plays a crucial role in angiogenesis, the process of new blood vessel formation from pre-existing vessels. VEGFA stimulates the proliferation and migration of endothelial cells, which line the interior surface of blood vessels, thereby contributing to the growth and development of new vasculature. This protein is essential for physiological processes such as embryonic development and wound healing, but it has also been implicated in various pathological conditions, including cancer, age-related macular degeneration, and diabetic retinopathy. The regulation of VEGFA expression and activity is critical to maintaining proper vascular function and homeostasis.

Pathologic neovascularization is the abnormal growth of new blood vessels in previously avascular tissue or excessive growth within existing vasculature, which occurs as a result of hypoxia, inflammation, or angiogenic stimuli. These newly formed vessels are often disorganized, fragile, and lack proper vessel hierarchy, leading to impaired blood flow and increased vascular permeability. Pathologic neovascularization can be observed in various diseases such as cancer, diabetic retinopathy, age-related macular degeneration, and chronic inflammation. This process contributes to disease progression by promoting tumor growth, metastasis, and edema formation, ultimately leading to tissue damage and organ dysfunction.

Retinal diseases refer to a group of conditions that affect the retina, which is the light-sensitive tissue located at the back of the eye. The retina is responsible for converting light into electrical signals that are sent to the brain and interpreted as visual images. Retinal diseases can cause vision loss or even blindness, depending on their severity and location in the retina.

Some common retinal diseases include:

1. Age-related macular degeneration (AMD): A progressive disease that affects the central part of the retina called the macula, causing blurred or distorted vision.
2. Diabetic retinopathy: A complication of diabetes that can damage the blood vessels in the retina, leading to vision loss.
3. Retinal detachment: A serious condition where the retina becomes separated from its underlying tissue, requiring immediate medical attention.
4. Macular edema: Swelling or thickening of the macula due to fluid accumulation, which can cause blurred vision.
5. Retinitis pigmentosa: A group of inherited eye disorders that affect the retina's ability to respond to light, causing progressive vision loss.
6. Macular hole: A small break in the macula that can cause distorted or blurry vision.
7. Retinal vein occlusion: Blockage of the retinal veins that can lead to bleeding, swelling, and potential vision loss.

Treatment for retinal diseases varies depending on the specific condition and its severity. Some treatments include medication, laser therapy, surgery, or a combination of these options. Regular eye exams are essential for early detection and treatment of retinal diseases.

Physiologic neovascularization is the natural and controlled formation of new blood vessels in the body, which occurs as a part of normal growth and development, as well as in response to tissue repair and wound healing. This process involves the activation of endothelial cells, which line the interior surface of blood vessels, and their migration, proliferation, and tube formation to create new capillaries. Physiologic neovascularization is tightly regulated by a balance of pro-angiogenic and anti-angiogenic factors, ensuring that it occurs only when and where it is needed. It plays crucial roles in various physiological processes, such as embryonic development, tissue regeneration, and wound healing.

Fluorescein angiography is a medical diagnostic procedure used in ophthalmology to examine the blood flow in the retina and choroid, which are the inner layers of the eye. This test involves injecting a fluorescent dye, Fluorescein, into a patient's arm vein. As the dye reaches the blood vessels in the eye, a specialized camera takes rapid sequences of photographs to capture the dye's circulation through the retina and choroid.

The images produced by fluorescein angiography can help doctors identify any damage to the blood vessels, leakage, or abnormal growth of new blood vessels. This information is crucial in diagnosing and managing various eye conditions such as age-related macular degeneration, diabetic retinopathy, retinal vein occlusions, and inflammatory eye diseases.

It's important to note that while fluorescein angiography is a valuable diagnostic tool, it does carry some risks, including temporary side effects like nausea, vomiting, or allergic reactions to the dye. In rare cases, severe adverse reactions can occur, so patients should discuss these potential risks with their healthcare provider before undergoing the procedure.

The retina is the innermost, light-sensitive layer of tissue in the eye of many vertebrates and some cephalopods. It receives light that has been focused by the cornea and lens, converts it into neural signals, and sends these to the brain via the optic nerve. The retina contains several types of photoreceptor cells including rods (which handle vision in low light) and cones (which are active in bright light and are capable of color vision).

In medical terms, any pathological changes or diseases affecting the retinal structure and function can lead to visual impairment or blindness. Examples include age-related macular degeneration, diabetic retinopathy, retinal detachment, and retinitis pigmentosa among others.

Hyperoxia is a medical term that refers to an abnormally high concentration of oxygen in the body or in a specific organ or tissue. It is often defined as the partial pressure of oxygen (PaO2) in arterial blood being greater than 100 mmHg.

This condition can occur due to various reasons such as exposure to high concentrations of oxygen during medical treatments, like mechanical ventilation, or due to certain diseases and conditions that cause the body to produce too much oxygen.

While oxygen is essential for human life, excessive levels can be harmful and lead to oxidative stress, which can damage cells and tissues. Hyperoxia has been linked to various complications, including lung injury, retinopathy of prematurity, and impaired wound healing.

Ischemia is the medical term used to describe a lack of blood flow to a part of the body, often due to blocked or narrowed blood vessels. This can lead to a shortage of oxygen and nutrients in the tissues, which can cause them to become damaged or die. Ischemia can affect many different parts of the body, including the heart, brain, legs, and intestines. Symptoms of ischemia depend on the location and severity of the blockage, but they may include pain, cramping, numbness, weakness, or coldness in the affected area. In severe cases, ischemia can lead to tissue death (gangrene) or organ failure. Treatment for ischemia typically involves addressing the underlying cause of the blocked blood flow, such as through medication, surgery, or lifestyle changes.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

The vitreous body, also known simply as the vitreous, is the clear, gel-like substance that fills the space between the lens and the retina in the eye. It is composed mainly of water, but also contains collagen fibers, hyaluronic acid, and other proteins. The vitreous helps to maintain the shape of the eye and provides a transparent medium for light to pass through to reach the retina. With age, the vitreous can become more liquefied and may eventually separate from the retina, leading to symptoms such as floaters or flashes of light.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

Angiogenesis inhibitors are a class of drugs that block the growth of new blood vessels (angiogenesis). They work by targeting specific molecules involved in the process of angiogenesis, such as vascular endothelial growth factor (VEGF) and its receptors. By blocking these molecules, angiogenesis inhibitors can prevent the development of new blood vessels that feed tumors, thereby slowing or stopping their growth.

Angiogenesis inhibitors are used in the treatment of various types of cancer, including colon, lung, breast, kidney, and ovarian cancer. They may be given alone or in combination with other cancer treatments, such as chemotherapy or radiation therapy. Some examples of angiogenesis inhibitors include bevacizumab (Avastin), sorafenib (Nexavar), sunitinib (Sutent), and pazopanib (Votrient).

It's important to note that while angiogenesis inhibitors can be effective in treating cancer, they can also have serious side effects, such as high blood pressure, bleeding, and damage to the heart or kidneys. Therefore, it's essential that patients receive careful monitoring and management of these potential side effects while undergoing treatment with angiogenesis inhibitors.

Oxygen is a colorless, odorless, tasteless gas that constitutes about 21% of the earth's atmosphere. It is a crucial element for human and most living organisms as it is vital for respiration. Inhaled oxygen enters the lungs and binds to hemoglobin in red blood cells, which carries it to tissues throughout the body where it is used to convert nutrients into energy and carbon dioxide, a waste product that is exhaled.

Medically, supplemental oxygen therapy may be provided to patients with conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, heart failure, or other medical conditions that impair the body's ability to extract sufficient oxygen from the air. Oxygen can be administered through various devices, including nasal cannulas, face masks, and ventilators.

Leukostasis is not a formal medical diagnosis, but rather a complication that can occur in certain medical conditions. It's often used in the context of leukemia, where there is a rapid accumulation of white blood cells (leukocytes) in the small blood vessels, leading to impaired circulation, particularly in the lungs and brain. This can result in symptoms such as shortness of breath, cough, chest pain, headache, altered mental status, or even stroke. It's a medical emergency that requires immediate treatment, often involving leukopheresis (a procedure to remove white blood cells from the blood) and chemotherapy.

"Newborn animals" refers to the very young offspring of animals that have recently been born. In medical terminology, newborns are often referred to as "neonates," and they are classified as such from birth until about 28 days of age. During this time period, newborn animals are particularly vulnerable and require close monitoring and care to ensure their survival and healthy development.

The specific needs of newborn animals can vary widely depending on the species, but generally, they require warmth, nutrition, hydration, and protection from harm. In many cases, newborns are unable to regulate their own body temperature or feed themselves, so they rely heavily on their mothers for care and support.

In medical settings, newborn animals may be examined and treated by veterinarians to ensure that they are healthy and receiving the care they need. This can include providing medical interventions such as feeding tubes, antibiotics, or other treatments as needed to address any health issues that arise. Overall, the care and support of newborn animals is an important aspect of animal medicine and conservation efforts.

An intravitreal injection is a medical procedure in which medication is delivered directly into the vitreous cavity of the eye, which is the clear, gel-like substance that fills the space between the lens and the retina. This type of injection is typically used to treat various eye conditions such as age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and uveitis. The medication administered in intravitreal injections can help to reduce inflammation, inhibit the growth of new blood vessels, or prevent the formation of abnormal blood vessels in the eye.

Intravitreal injections are usually performed in an outpatient setting, and the procedure typically takes only a few minutes. Before the injection, the eye is numbed with anesthetic drops to minimize discomfort. The medication is then injected into the vitreous cavity using a small needle. After the injection, patients may experience some mild discomfort or a scratchy sensation in the eye, but this usually resolves within a few hours.

While intravitreal injections are generally safe, there are some potential risks and complications associated with the procedure, including infection, bleeding, retinal detachment, and increased intraocular pressure. Patients who undergo intravitreal injections should be closely monitored by their eye care provider to ensure that any complications are promptly identified and treated.

Diabetic retinopathy is a diabetes complication that affects the eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina).

At first, diabetic retinopathy may cause no symptoms or only mild vision problems. Eventually, it can cause blindness. The condition usually affects both eyes.

There are two main stages of diabetic retinopathy:

1. Early diabetic retinopathy. This is when the blood vessels in the eye start to leak fluid or bleed. You might not notice any changes in your vision at this stage, but it's still important to get treatment because it can prevent the condition from getting worse.
2. Advanced diabetic retinopathy. This is when new, abnormal blood vessels grow on the surface of the retina. These vessels can leak fluid and cause severe vision problems, including blindness.

Diabetic retinopathy can be treated with laser surgery, injections of medication into the eye, or a vitrectomy (a surgical procedure to remove the gel-like substance that fills the center of the eye). It's important to get regular eye exams to detect diabetic retinopathy early and get treatment before it causes serious vision problems.

Vascular Endothelial Growth Factors (VEGFs) are a family of signaling proteins that stimulate the growth and development of new blood vessels, a process known as angiogenesis. They play crucial roles in both physiological and pathological conditions, such as embryonic development, wound healing, and tumor growth. Specifically, VEGFs bind to specific receptors on the surface of endothelial cells, which line the interior surface of blood vessels, triggering a cascade of intracellular signaling events that promote cell proliferation, migration, and survival. Dysregulation of VEGF signaling has been implicated in various diseases, including cancer, age-related macular degeneration, and diabetic retinopathy.

SERPINs are an acronym for "serine protease inhibitors." They are a group of proteins that inhibit serine proteases, which are enzymes that cut other proteins. SERPINs are found in various tissues and body fluids, including blood, and play important roles in regulating biological processes such as inflammation, blood clotting, and cell death. They do this by forming covalent complexes with their target proteases, thereby preventing them from carrying out their proteolytic activities. Mutations in SERPIN genes have been associated with several genetic disorders, including emphysema, cirrhosis, and dementia.

Endothelial growth factors (ECGFs or EGFs) are a group of signaling proteins that stimulate the growth, proliferation, and survival of endothelial cells, which line the interior surface of blood vessels. These growth factors play crucial roles in various physiological processes, including angiogenesis (the formation of new blood vessels), wound healing, and vascular development during embryogenesis.

One of the most well-studied EGFs is the vascular endothelial growth factor (VEGF) family, which consists of several members like VEGFA, VEGFB, VEGFC, VEGFD, and placental growth factor (PlGF). These factors bind to specific receptors on the surface of endothelial cells, leading to a cascade of intracellular signaling events that ultimately result in cell proliferation, migration, and survival.

Other EGFs include fibroblast growth factors (FGFs), hepatocyte growth factor (HGF), platelet-derived growth factor (PDGF), and transforming growth factor-beta (TGF-β). Dysregulation of endothelial growth factors has been implicated in various pathological conditions, such as cancer, diabetic retinopathy, age-related macular degeneration, and cardiovascular diseases. Therefore, understanding the functions and regulation of EGFs is essential for developing novel therapeutic strategies to treat these disorders.

Lymphokines are a type of cytokines that are produced and released by activated lymphocytes, a type of white blood cell, in response to an antigenic stimulation. They play a crucial role in the regulation of immune responses and inflammation. Lymphokines can mediate various biological activities such as chemotaxis, activation, proliferation, and differentiation of different immune cells including lymphocytes, monocytes, macrophages, and eosinophils. Examples of lymphokines include interleukins (ILs), interferons (IFNs), tumor necrosis factor (TNF), and colony-stimulating factors (CSFs).

"Light coagulation," also known as "laser coagulation," is a medical term that refers to the use of laser technology to cauterize (seal or close) tissue. This procedure uses heat generated by a laser to cut, coagulate, or destroy tissue. In light coagulation, the laser beam is focused on the blood vessels in question, causing the blood within them to clot and the vessels to seal. This can be used for various medical purposes, such as stopping bleeding during surgery, destroying abnormal tissues (like tumors), or treating eye conditions like diabetic retinopathy and age-related macular degeneration.

It's important to note that this is a general definition, and the specific use of light coagulation may vary depending on the medical specialty and the individual patient's needs. As always, it's best to consult with a healthcare professional for more detailed information about any medical procedure or treatment.

An injection is a medical procedure in which a medication, vaccine, or other substance is introduced into the body using a needle and syringe. The substance can be delivered into various parts of the body, including into a vein (intravenous), muscle (intramuscular), under the skin (subcutaneous), or into the spinal canal (intrathecal or spinal).

Injections are commonly used to administer medications that cannot be taken orally, have poor oral bioavailability, need to reach the site of action quickly, or require direct delivery to a specific organ or tissue. They can also be used for diagnostic purposes, such as drawing blood samples (venipuncture) or injecting contrast agents for imaging studies.

Proper technique and sterile conditions are essential when administering injections to prevent infection, pain, and other complications. The choice of injection site depends on the type and volume of the substance being administered, as well as the patient's age, health status, and personal preferences.

"Fundus Oculi" is a medical term that refers to the back part of the interior of the eye, including the optic disc, macula, fovea, retinal vasculature, and peripheral retina. It is the area where light is focused and then transmitted to the brain via the optic nerve, forming visual images. Examinations of the fundus oculi are crucial for detecting various eye conditions such as diabetic retinopathy, macular degeneration, glaucoma, and other retinal diseases. The examination is typically performed using an ophthalmoscope or a specialized camera called a retinal camera.

Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) is a tyrosine kinase receptor that is primarily expressed on vascular endothelial cells. It is a crucial regulator of angiogenesis, the process of new blood vessel formation from pre-existing vessels. VEGFR-2 is activated by binding to its ligand, Vascular Endothelial Growth Factor-A (VEGF-A), leading to receptor dimerization and autophosphorylation. This activation triggers a cascade of intracellular signaling events that promote endothelial cell proliferation, migration, survival, and vascular permeability, all essential steps in the angiogenic process.

VEGFR-2 plays a significant role in physiological and pathological conditions associated with angiogenesis, such as embryonic development, wound healing, tumor growth, and retinopathies. Inhibition of VEGFR-2 signaling has been an attractive target for anti-angiogenic therapies in various diseases, including cancer and age-related macular degeneration.

The blood-retinal barrier (BRB) is a specialized physiological barrier in the eye that helps regulate the movement of molecules between the retina and the bloodstream. It is made up of tight junctions between the endothelial cells of retinal blood vessels and between the pigment epithelium cells of the retina, which restrict the paracellular diffusion of solutes.

The BRB plays a crucial role in maintaining the health and function of the retina by preventing harmful substances from entering the retina while allowing essential nutrients and oxygen to reach the retinal tissues. Disruption of the BRB has been implicated in various retinal diseases, including diabetic retinopathy, age-related macular degeneration, and retinal vein occlusion.

Endothelial cells are the type of cells that line the inner surface of blood vessels, lymphatic vessels, and heart chambers. They play a crucial role in maintaining vascular homeostasis by controlling vasomotor tone, coagulation, platelet activation, and inflammation. Endothelial cells also regulate the transport of molecules between the blood and surrounding tissues, and contribute to the maintenance of the structural integrity of the vasculature. They are flat, elongated cells with a unique morphology that allows them to form a continuous, nonthrombogenic lining inside the vessels. Endothelial cells can be isolated from various tissues and cultured in vitro for research purposes.

The endothelium is a thin layer of simple squamous epithelial cells that lines the interior surface of blood vessels, lymphatic vessels, and heart chambers. The vascular endothelium, specifically, refers to the endothelial cells that line the blood vessels. These cells play a crucial role in maintaining vascular homeostasis by regulating vasomotor tone, coagulation, platelet activation, inflammation, and permeability of the vessel wall. They also contribute to the growth and repair of the vascular system and are involved in various pathological processes such as atherosclerosis, hypertension, and diabetes.

The Fluorescent Antibody Technique (FAT), Indirect is a type of immunofluorescence assay used to detect the presence of specific antigens in a sample. In this method, the sample is first incubated with a primary antibody that binds to the target antigen. After washing to remove unbound primary antibodies, a secondary fluorescently labeled antibody is added, which recognizes and binds to the primary antibody. This indirect labeling approach allows for amplification of the signal, making it more sensitive than direct methods. The sample is then examined under a fluorescence microscope to visualize the location and amount of antigen based on the emitted light from the fluorescent secondary antibody. It's commonly used in diagnostic laboratories for detection of various bacteria, viruses, and other antigens in clinical specimens.

Anoxia is a medical condition that refers to the absence or complete lack of oxygen supply in the body or a specific organ, tissue, or cell. This can lead to serious health consequences, including damage or death of cells and tissues, due to the vital role that oxygen plays in supporting cellular metabolism and energy production.

Anoxia can occur due to various reasons, such as respiratory failure, cardiac arrest, severe blood loss, carbon monoxide poisoning, or high altitude exposure. Prolonged anoxia can result in hypoxic-ischemic encephalopathy, a serious condition that can cause brain damage and long-term neurological impairments.

Medical professionals use various diagnostic tests, such as blood gas analysis, pulse oximetry, and electroencephalography (EEG), to assess oxygen levels in the body and diagnose anoxia. Treatment for anoxia typically involves addressing the underlying cause, providing supplemental oxygen, and supporting vital functions, such as breathing and circulation, to prevent further damage.

Cell movement, also known as cell motility, refers to the ability of cells to move independently and change their location within tissue or inside the body. This process is essential for various biological functions, including embryonic development, wound healing, immune responses, and cancer metastasis.

There are several types of cell movement, including:

1. **Crawling or mesenchymal migration:** Cells move by extending and retracting protrusions called pseudopodia or filopodia, which contain actin filaments. This type of movement is common in fibroblasts, immune cells, and cancer cells during tissue invasion and metastasis.
2. **Amoeboid migration:** Cells move by changing their shape and squeezing through tight spaces without forming protrusions. This type of movement is often observed in white blood cells (leukocytes) as they migrate through the body to fight infections.
3. **Pseudopodial extension:** Cells extend pseudopodia, which are temporary cytoplasmic projections containing actin filaments. These protrusions help the cell explore its environment and move forward.
4. **Bacterial flagellar motion:** Bacteria use a whip-like structure called a flagellum to propel themselves through their environment. The rotation of the flagellum is driven by a molecular motor in the bacterial cell membrane.
5. **Ciliary and ependymal movement:** Ciliated cells, such as those lining the respiratory tract and fallopian tubes, have hair-like structures called cilia that beat in coordinated waves to move fluids or mucus across the cell surface.

Cell movement is regulated by a complex interplay of signaling pathways, cytoskeletal rearrangements, and adhesion molecules, which enable cells to respond to environmental cues and navigate through tissues.

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a laboratory technique used in molecular biology to amplify and detect specific DNA sequences. This technique is particularly useful for the detection and quantification of RNA viruses, as well as for the analysis of gene expression.

The process involves two main steps: reverse transcription and polymerase chain reaction (PCR). In the first step, reverse transcriptase enzyme is used to convert RNA into complementary DNA (cDNA) by reading the template provided by the RNA molecule. This cDNA then serves as a template for the PCR amplification step.

In the second step, the PCR reaction uses two primers that flank the target DNA sequence and a thermostable polymerase enzyme to repeatedly copy the targeted cDNA sequence. The reaction mixture is heated and cooled in cycles, allowing the primers to anneal to the template, and the polymerase to extend the new strand. This results in exponential amplification of the target DNA sequence, making it possible to detect even small amounts of RNA or cDNA.

RT-PCR is a sensitive and specific technique that has many applications in medical research and diagnostics, including the detection of viruses such as HIV, hepatitis C virus, and SARS-CoV-2 (the virus that causes COVID-19). It can also be used to study gene expression, identify genetic mutations, and diagnose genetic disorders.

Eye proteins, also known as ocular proteins, are specific proteins that are found within the eye and play crucial roles in maintaining proper eye function and health. These proteins can be found in various parts of the eye, including the cornea, iris, lens, retina, and other structures. They perform a wide range of functions, such as:

1. Structural support: Proteins like collagen and elastin provide strength and flexibility to the eye's tissues, enabling them to maintain their shape and withstand mechanical stress.
2. Light absorption and transmission: Proteins like opsins and crystallins are involved in capturing and transmitting light signals within the eye, which is essential for vision.
3. Protection against damage: Some eye proteins, such as antioxidant enzymes and heat shock proteins, help protect the eye from oxidative stress, UV radiation, and other environmental factors that can cause damage.
4. Regulation of eye growth and development: Various growth factors and signaling molecules, which are protein-based, contribute to the proper growth, differentiation, and maintenance of eye tissues during embryonic development and throughout adulthood.
5. Immune defense: Proteins involved in the immune response, such as complement components and immunoglobulins, help protect the eye from infection and inflammation.
6. Maintenance of transparency: Crystallin proteins in the lens maintain its transparency, allowing light to pass through unobstructed for clear vision.
7. Neuroprotection: Certain eye proteins, like brain-derived neurotrophic factor (BDNF), support the survival and function of neurons within the retina, helping to preserve vision.

Dysfunction or damage to these eye proteins can contribute to various eye disorders and diseases, such as cataracts, age-related macular degeneration, glaucoma, diabetic retinopathy, and others.

A Vitreous Hemorrhage is a medical condition where there is bleeding into the vitreous cavity of the eye. The vitreous cavity is the space in the eye that is filled with a clear, gel-like substance called the vitreous humor. This substance helps to maintain the shape of the eye and transmit light to the retina.

When a vitreous hemorrhage occurs, blood cells from the bleeding mix with the vitreous humor, causing it to become cloudy or hazy. As a result, vision can become significantly impaired, ranging from mildly blurry to complete loss of vision depending on the severity of the bleed.

Vitreous hemorrhages can occur due to various reasons such as trauma, retinal tears or detachments, diabetic retinopathy, age-related macular degeneration, and other eye conditions that affect the blood vessels in the eye. Treatment for vitreous hemorrhage depends on the underlying cause and may include observation, laser surgery, or vitrectomy (a surgical procedure to remove the vitreous humor and stop the bleeding).

Nerve Growth Factors (NGFs) are a family of proteins that play an essential role in the growth, maintenance, and survival of certain neurons (nerve cells). They were first discovered by Rita Levi-Montalcini and Stanley Cohen in 1956. NGF is particularly crucial for the development and function of the peripheral nervous system, which connects the central nervous system to various organs and tissues throughout the body.

NGF supports the differentiation and survival of sympathetic and sensory neurons during embryonic development. In adults, NGF continues to regulate the maintenance and repair of these neurons, contributing to neuroplasticity – the brain's ability to adapt and change over time. Additionally, NGF has been implicated in pain transmission and modulation, as well as inflammatory responses.

Abnormal levels or dysfunctional NGF signaling have been associated with various medical conditions, including neurodegenerative diseases (e.g., Alzheimer's and Parkinson's), chronic pain disorders, and certain cancers (e.g., small cell lung cancer). Therefore, understanding the role of NGF in physiological and pathological processes may provide valuable insights into developing novel therapeutic strategies for these conditions.

Capillaries are the smallest blood vessels in the body, with diameters that range from 5 to 10 micrometers. They form a network of tiny tubes that connect the arterioles (small branches of arteries) and venules (small branches of veins), allowing for the exchange of oxygen, carbon dioxide, nutrients, and waste products between the blood and the surrounding tissues.

Capillaries are composed of a single layer of endothelial cells that surround a hollow lumen through which blood flows. The walls of capillaries are extremely thin, allowing for easy diffusion of molecules between the blood and the surrounding tissue. This is essential for maintaining the health and function of all body tissues.

Capillaries can be classified into three types based on their structure and function: continuous, fenestrated, and sinusoidal. Continuous capillaries have a continuous layer of endothelial cells with tight junctions that restrict the passage of large molecules. Fenestrated capillaries have small pores or "fenestrae" in the endothelial cell walls that allow for the passage of larger molecules, such as proteins and lipids. Sinusoidal capillaries are found in organs with high metabolic activity, such as the liver and spleen, and have large, irregular spaces between the endothelial cells that allow for the exchange of even larger molecules.

Overall, capillaries play a critical role in maintaining the health and function of all body tissues by allowing for the exchange of nutrients, oxygen, and waste products between the blood and surrounding tissues.

"Ligusticum" is a genus name in botany, which refers to a group of plants belonging to the carrot family (Apiaceae). There are several species within this genus, including "Ligusticum porteri" and "Ligusticum sinense," which have been used in traditional medicine.

In a medical context, "Ligusticum" is not commonly used as a standalone term but rather refers to the medicinal properties of specific species within this genus. For example, "Ligusticum porteri," also known as Osha or Porter's Lovage, has been traditionally used in Native American medicine for treating respiratory and digestive issues. Similarly, "Ligusticum sinense," or Chinese Lovage, is commonly used in Traditional Chinese Medicine (TCM) to treat various conditions such as cough, asthma, and menstrual disorders.

It's important to note that while some species of Ligusticum have been used in traditional medicine, there is limited scientific evidence to support their efficacy or safety. Therefore, it's recommended to consult with a healthcare professional before using any herbal remedies.

Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.

Western blotting is a laboratory technique used in molecular biology to detect and quantify specific proteins in a mixture of many different proteins. This technique is commonly used to confirm the expression of a protein of interest, determine its size, and investigate its post-translational modifications. The name "Western" blotting distinguishes this technique from Southern blotting (for DNA) and Northern blotting (for RNA).

The Western blotting procedure involves several steps:

1. Protein extraction: The sample containing the proteins of interest is first extracted, often by breaking open cells or tissues and using a buffer to extract the proteins.
2. Separation of proteins by electrophoresis: The extracted proteins are then separated based on their size by loading them onto a polyacrylamide gel and running an electric current through the gel (a process called sodium dodecyl sulfate-polyacrylamide gel electrophoresis or SDS-PAGE). This separates the proteins according to their molecular weight, with smaller proteins migrating faster than larger ones.
3. Transfer of proteins to a membrane: After separation, the proteins are transferred from the gel onto a nitrocellulose or polyvinylidene fluoride (PVDF) membrane using an electric current in a process called blotting. This creates a replica of the protein pattern on the gel but now immobilized on the membrane for further analysis.
4. Blocking: The membrane is then blocked with a blocking agent, such as non-fat dry milk or bovine serum albumin (BSA), to prevent non-specific binding of antibodies in subsequent steps.
5. Primary antibody incubation: A primary antibody that specifically recognizes the protein of interest is added and allowed to bind to its target protein on the membrane. This step may be performed at room temperature or 4°C overnight, depending on the antibody's properties.
6. Washing: The membrane is washed with a buffer to remove unbound primary antibodies.
7. Secondary antibody incubation: A secondary antibody that recognizes the primary antibody (often coupled to an enzyme or fluorophore) is added and allowed to bind to the primary antibody. This step may involve using a horseradish peroxidase (HRP)-conjugated or alkaline phosphatase (AP)-conjugated secondary antibody, depending on the detection method used later.
8. Washing: The membrane is washed again to remove unbound secondary antibodies.
9. Detection: A detection reagent is added to visualize the protein of interest by detecting the signal generated from the enzyme-conjugated or fluorophore-conjugated secondary antibody. This can be done using chemiluminescent, colorimetric, or fluorescent methods.
10. Analysis: The resulting image is analyzed to determine the presence and quantity of the protein of interest in the sample.

Western blotting is a powerful technique for identifying and quantifying specific proteins within complex mixtures. It can be used to study protein expression, post-translational modifications, protein-protein interactions, and more. However, it requires careful optimization and validation to ensure accurate and reproducible results.

"Intraperitoneal injection" is a medical term that refers to the administration of a substance or medication directly into the peritoneal cavity, which is the space between the lining of the abdominal wall and the organs contained within it. This type of injection is typically used in clinical settings for various purposes, such as delivering chemotherapy drugs, anesthetics, or other medications directly to the abdominal organs.

The procedure involves inserting a needle through the abdominal wall and into the peritoneal cavity, taking care to avoid any vital structures such as blood vessels or nerves. Once the needle is properly positioned, the medication can be injected slowly and carefully to ensure even distribution throughout the cavity.

It's important to note that intraperitoneal injections are typically reserved for situations where other routes of administration are not feasible or effective, as they carry a higher risk of complications such as infection, bleeding, or injury to surrounding organs. As with any medical procedure, it should only be performed by trained healthcare professionals under appropriate clinical circumstances.

Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1), also known as Flt-1 (Fms-like tyrosine kinase-1), is a receptor tyrosine kinase that plays a crucial role in the regulation of angiogenesis, vasculogenesis, and lymphangiogenesis. It is primarily expressed on vascular endothelial cells, hematopoietic stem cells, and monocytes/macrophages. VEGFR-1 binds to several ligands, including Vascular Endothelial Growth Factor-A (VEGF-A), VEGF-B, and Placental Growth Factor (PlGF). The binding of these ligands to VEGFR-1 triggers intracellular signaling cascades that modulate various cellular responses, such as proliferation, migration, survival, and vascular permeability. While VEGFR-1 is known to have a role in promoting angiogenesis under certain conditions, it primarily acts as a negative regulator of angiogenesis by sequestering VEGF-A, preventing its binding to the more proangiogenic VEGFR-2 receptor. Dysregulation of VEGFR-1 signaling has been implicated in various pathological conditions, including cancer, inflammation, and vascular diseases.

"Rats, Inbred BN" are a strain of laboratory rats (Rattus norvegicus) that have been inbred for many generations to maintain a high level of genetic consistency and uniformity within the strain. The "BN" designation refers to the place where they were first developed, Bratislava, Czechoslovakia (now Slovakia).

These rats are often used in biomedical research because their genetic homogeneity makes them useful for studying the effects of specific genes or environmental factors on health and disease. They have been widely used as a model organism to study various physiological and pathophysiological processes, including hypertension, kidney function, immunology, and neuroscience.

Inbred BN rats are known for their low renin-angiotensin system activity, which makes them a useful model for studying hypertension and related disorders. They also have a unique sensitivity to dietary protein, making them a valuable tool for studying the relationship between diet and kidney function.

Overall, Inbred BN rats are an important tool in biomedical research, providing researchers with a consistent and well-characterized model organism for studying various aspects of human health and disease.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

Angiopoietin-2 (Ang-2) is a protein that is involved in the regulation of blood vessel formation and maintenance. It is a member of the angiopoietin family, which includes Ang-1, Ang-2, Ang-3, and Ang-4. These proteins bind to the Tie receptor tyrosine kinases (Tie1 and Tie2) on the surface of endothelial cells, which line the interior of blood vessels.

Ang-2 is primarily produced by endothelial cells and has context-dependent roles in angiogenesis, which is the growth of new blood vessels from pre-existing ones. In general, Ang-2 is thought to act as an antagonist of Ang-1, which promotes vessel stability and maturation.

Ang-2 can destabilize existing blood vessels by binding to Tie2 receptors and blocking the stabilizing effects of Ang-1. This can lead to increased vascular permeability and inflammation. However, in the presence of pro-angiogenic factors such as VEGF (vascular endothelial growth factor), Ang-2 can also promote the formation of new blood vessels by stimulating endothelial cell migration and proliferation.

Abnormal regulation of Ang-2 has been implicated in various diseases, including cancer, diabetic retinopathy, and age-related macular degeneration. In these conditions, increased levels of Ang-2 can contribute to the development of abnormal blood vessels, which can lead to tissue damage and loss of function.

TEC (Tyrosine kinase with Immunoglobulin-like and EGF homology domains-2) or TIE-2 is a type of receptor tyrosine kinase that plays a crucial role in the regulation of angiogenesis, lymphangiogenesis, and vascular maintenance. It is primarily expressed on the surface of endothelial cells, which line the interior surface of blood vessels.

The TIE-2 receptor binds to its ligand, angiopoietin-1 (Ang1), promoting vessel stability and quiescence by reducing endothelial cell permeability and enhancing their survival. Angiopoietin-2 (Ang2) can also bind to the TIE-2 receptor but with lower affinity than Ang1, acting as a context-dependent agonist or antagonist. In the presence of VEGF (Vascular Endothelial Growth Factor), Ang2 functions as an antagonist, inducing vascular instability and increasing endothelial cell permeability, which contributes to angiogenesis during development and in pathological conditions like tumor growth, inflammation, and ischemia.

Abnormal TIE-2 signaling has been implicated in several diseases, including cancer, atherosclerosis, and diabetic retinopathy. Targeting the TIE-2 signaling pathway presents an attractive therapeutic strategy for treating these conditions.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

Vascular endothelial growth factor (VEGF) receptors are a type of cell surface receptor that play crucial roles in the process of angiogenesis, which is the formation of new blood vessels from pre-existing ones. These receptors bind to VEGF proteins, leading to a cascade of intracellular signaling events that ultimately result in the proliferation, migration, and survival of endothelial cells, which line the interior surface of blood vessels. There are three main types of VEGF receptors: VEGFR-1, VEGFR-2, and VEGFR-3. These receptors have distinct roles in angiogenesis, with VEGFR-2 being the primary mediator of this process. Dysregulation of VEGF signaling has been implicated in various diseases, including cancer, age-related macular degeneration, and diabetic retinopathy, making VEGF receptors important targets for therapeutic intervention.

Human Umbilical Vein Endothelial Cells (HUVECs) are a type of primary cells that are isolated from the umbilical cord vein of human placenta. These cells are naturally equipped with endothelial properties and functions, making them an essential tool in biomedical research. HUVECs line the interior surface of blood vessels and play a crucial role in the regulation of vascular function, including angiogenesis (the formation of new blood vessels), coagulation, and permeability. Due to their accessibility and high proliferation rate, HUVECs are widely used in various research areas such as vascular biology, toxicology, drug development, and gene therapy.

Perylene is not a medical term, but a chemical compound. It is an organic compound that is classified as a polycyclic aromatic hydrocarbon (PAH). PAHs are formed from the incomplete combustion of coal, oil, gas, wood, garbage, or other organic substances.

In medicine, perylene may be used in research and diagnostic settings to study cellular processes and diseases. For example, perylene derivatives have been used as fluorescent probes to investigate the structure and function of lipid membranes, DNA, and proteins. However, perylene itself is not a medical treatment or therapy.

The choroid is a layer of the eye that contains blood vessels that supply oxygen and nutrients to the outer layers of the retina. It lies between the sclera (the white, protective coat of the eye) and the retina (the light-sensitive tissue at the back of the eye). The choroid is essential for maintaining the health and function of the retina, particularly the photoreceptor cells that detect light and transmit visual signals to the brain. Damage to the choroid can lead to vision loss or impairment.

Immunoenzyme techniques are a group of laboratory methods used in immunology and clinical chemistry that combine the specificity of antibody-antigen reactions with the sensitivity and amplification capabilities of enzyme reactions. These techniques are primarily used for the detection, quantitation, or identification of various analytes (such as proteins, hormones, drugs, viruses, or bacteria) in biological samples.

In immunoenzyme techniques, an enzyme is linked to an antibody or antigen, creating a conjugate. This conjugate then interacts with the target analyte in the sample, forming an immune complex. The presence and amount of this immune complex can be visualized or measured by detecting the enzymatic activity associated with it.

There are several types of immunoenzyme techniques, including:

1. Enzyme-linked Immunosorbent Assay (ELISA): A widely used method for detecting and quantifying various analytes in a sample. In ELISA, an enzyme is attached to either the capture antibody or the detection antibody. After the immune complex formation, a substrate is added that reacts with the enzyme, producing a colored product that can be measured spectrophotometrically.
2. Immunoblotting (Western blot): A method used for detecting specific proteins in a complex mixture, such as a protein extract from cells or tissues. In this technique, proteins are separated by gel electrophoresis and transferred to a membrane, where they are probed with an enzyme-conjugated antibody directed against the target protein.
3. Immunohistochemistry (IHC): A method used for detecting specific antigens in tissue sections or cells. In IHC, an enzyme-conjugated primary or secondary antibody is applied to the sample, and the presence of the antigen is visualized using a chromogenic substrate that produces a colored product at the site of the antigen-antibody interaction.
4. Immunofluorescence (IF): A method used for detecting specific antigens in cells or tissues by employing fluorophore-conjugated antibodies. The presence of the antigen is visualized using a fluorescence microscope.
5. Enzyme-linked immunosorbent assay (ELISA): A method used for detecting and quantifying specific antigens or antibodies in liquid samples, such as serum or culture supernatants. In ELISA, an enzyme-conjugated detection antibody is added after the immune complex formation, and a substrate is added that reacts with the enzyme to produce a colored product that can be measured spectrophotometrically.

These techniques are widely used in research and diagnostic laboratories for various applications, including protein characterization, disease diagnosis, and monitoring treatment responses.

A "knockout" mouse is a genetically engineered mouse in which one or more genes have been deleted or "knocked out" using molecular biology techniques. This allows researchers to study the function of specific genes and their role in various biological processes, as well as potential associations with human diseases. The mice are generated by introducing targeted DNA modifications into embryonic stem cells, which are then used to create a live animal. Knockout mice have been widely used in biomedical research to investigate gene function, disease mechanisms, and potential therapeutic targets.

Retinitis is a medical term that refers to the inflammation of the retina, which is the light-sensitive tissue located at the back of the eye. The retina is responsible for converting light into electrical signals that are then sent to the brain and interpreted as visual images. Retinitis can be caused by various factors, including infections, autoimmune diseases, or genetic conditions.

The inflammation associated with retinitis can affect any part of the retina, but it typically involves the retinal pigment epithelium (RPE) and the photoreceptor cells (rods and cones). Depending on the severity and location of the inflammation, retinitis can cause a range of visual symptoms, such as blurry vision, floaters, loss of peripheral vision, or night blindness.

Retinitis is often distinguished from another condition called retinopathy, which refers to damage to the retina caused by diabetes or other systemic diseases. While both conditions can affect the retina and cause visual symptoms, retinitis is characterized by inflammation, while retinopathy is characterized by damage due to circulatory problems.

It's important to note that retinitis is a serious condition that requires prompt medical attention. If left untreated, it can lead to permanent vision loss or blindness. Treatment options for retinitis depend on the underlying cause and may include antibiotics, corticosteroids, or other immunosuppressive medications.

In situ nick-end labeling (ISEL, also known as TUNEL) is a technique used in pathology and molecular biology to detect DNA fragmentation, which is a characteristic of apoptotic cells (cells undergoing programmed cell death). The method involves labeling the 3'-hydroxyl termini of double or single stranded DNA breaks in situ (within tissue sections or individual cells) using modified nucleotides that are coupled to a detectable marker, such as a fluorophore or an enzyme. This technique allows for the direct visualization and quantification of apoptotic cells within complex tissues or cell populations.

Microvessels are the smallest blood vessels in the body, including capillaries, venules, and arterioles. They form a crucial part of the circulatory system, responsible for delivering oxygen and nutrients to tissues and organs while removing waste products. Capillaries, the tiniest microvessels, facilitate the exchange of substances between blood and tissue cells through their thin walls. Overall, microvessels play a vital role in maintaining proper organ function and overall health.

Cell proliferation is the process by which cells increase in number, typically through the process of cell division. In the context of biology and medicine, it refers to the reproduction of cells that makes up living tissue, allowing growth, maintenance, and repair. It involves several stages including the transition from a phase of quiescence (G0 phase) to an active phase (G1 phase), DNA replication in the S phase, and mitosis or M phase, where the cell divides into two daughter cells.

Abnormal or uncontrolled cell proliferation is a characteristic feature of many diseases, including cancer, where deregulated cell cycle control leads to excessive and unregulated growth of cells, forming tumors that can invade surrounding tissues and metastasize to distant sites in the body.

Dextrans are a type of complex glucose polymers that are formed by the action of certain bacteria on sucrose. They are branched polysaccharides consisting of linear chains of α-1,6 linked D-glucopyranosyl units with occasional α-1,3 branches.

Dextrans have a wide range of applications in medicine and industry. In medicine, dextrans are used as plasma substitutes, volume expanders, and anticoagulants. They are also used as carriers for drugs and diagnostic agents, and in the manufacture of immunoadsorbents for the removal of toxins and pathogens from blood.

Dextrans can be derived from various bacterial sources, but the most common commercial source is Leuconostoc mesenteroides B-512(F) or L. dextranicum. The molecular weight of dextrans can vary widely, ranging from a few thousand to several million Daltons, depending on the method of preparation and purification.

Dextrans are generally biocompatible and non-toxic, but they can cause allergic reactions in some individuals. Therefore, their use as medical products requires careful monitoring and testing for safety and efficacy.

Laser coagulation, also known as laser photocoagulation, is a medical procedure that uses a laser to seal or destroy abnormal blood vessels or tissue. The laser produces a concentrated beam of light that can be precisely focused on the target area. When the laser energy is absorbed by the tissue, it causes the temperature to rise, which leads to coagulation (the formation of a clot) or destruction of the tissue.

In ophthalmology, laser coagulation is commonly used to treat conditions such as diabetic retinopathy, age-related macular degeneration, and retinal tears or holes. The procedure can help to seal leaking blood vessels, reduce fluid leakage, and prevent further vision loss. It is usually performed as an outpatient procedure and may be repeated if necessary.

In other medical specialties, laser coagulation may be used to control bleeding, destroy tumors, or remove unwanted tissue. The specific technique and parameters of the laser treatment will depend on the individual patient's needs and the condition being treated.

The cornea is the clear, dome-shaped surface at the front of the eye. It plays a crucial role in focusing vision. The cornea protects the eye from harmful particles and microorganisms, and it also serves as a barrier against UV light. Its transparency allows light to pass through and get focused onto the retina. The cornea does not contain blood vessels, so it relies on tears and the fluid inside the eye (aqueous humor) for nutrition and oxygen. Any damage or disease that affects its clarity and shape can significantly impact vision and potentially lead to blindness if left untreated.

"Cattle" is a term used in the agricultural and veterinary fields to refer to domesticated animals of the genus *Bos*, primarily *Bos taurus* (European cattle) and *Bos indicus* (Zebu). These animals are often raised for meat, milk, leather, and labor. They are also known as bovines or cows (for females), bulls (intact males), and steers/bullocks (castrated males). However, in a strict medical definition, "cattle" does not apply to humans or other animals.

The vasa vasorum are small blood vessels that supply larger blood vessels, such as the arteries and veins, with oxygen and nutrients. They are located in the outer layers (the adventitia and media) of these larger vessels and form a network of vessels that surround and penetrate the walls of the larger vessels. The vasa vasorum are particularly important in supplying blood to the thicker walls of larger arteries, such as the aorta, where diffusion from the lumen may not be sufficient to meet the metabolic needs of the vessel wall.

Capillary permeability refers to the ability of substances to pass through the walls of capillaries, which are the smallest blood vessels in the body. These tiny vessels connect the arterioles and venules, allowing for the exchange of nutrients, waste products, and gases between the blood and the surrounding tissues.

The capillary wall is composed of a single layer of endothelial cells that are held together by tight junctions. The permeability of these walls varies depending on the size and charge of the molecules attempting to pass through. Small, uncharged molecules such as water, oxygen, and carbon dioxide can easily diffuse through the capillary wall, while larger or charged molecules such as proteins and large ions have more difficulty passing through.

Increased capillary permeability can occur in response to inflammation, infection, or injury, allowing larger molecules and immune cells to enter the surrounding tissues. This can lead to swelling (edema) and tissue damage if not controlled. Decreased capillary permeability, on the other hand, can lead to impaired nutrient exchange and tissue hypoxia.

Overall, the permeability of capillaries is a critical factor in maintaining the health and function of tissues throughout the body.

Up-regulation is a term used in molecular biology and medicine to describe an increase in the expression or activity of a gene, protein, or receptor in response to a stimulus. This can occur through various mechanisms such as increased transcription, translation, or reduced degradation of the molecule. Up-regulation can have important functional consequences, for example, enhancing the sensitivity or response of a cell to a hormone, neurotransmitter, or drug. It is a normal physiological process that can also be induced by disease or pharmacological interventions.

An Enzyme-Linked Immunosorbent Assay (ELISA) is a type of analytical biochemistry assay used to detect and quantify the presence of a substance, typically a protein or peptide, in a liquid sample. It takes its name from the enzyme-linked antibodies used in the assay.

In an ELISA, the sample is added to a well containing a surface that has been treated to capture the target substance. If the target substance is present in the sample, it will bind to the surface. Next, an enzyme-linked antibody specific to the target substance is added. This antibody will bind to the captured target substance if it is present. After washing away any unbound material, a substrate for the enzyme is added. If the enzyme is present due to its linkage to the antibody, it will catalyze a reaction that produces a detectable signal, such as a color change or fluorescence. The intensity of this signal is proportional to the amount of target substance present in the sample, allowing for quantification.

ELISAs are widely used in research and clinical settings to detect and measure various substances, including hormones, viruses, and bacteria. They offer high sensitivity, specificity, and reproducibility, making them a reliable choice for many applications.

Transgenic mice are genetically modified rodents that have incorporated foreign DNA (exogenous DNA) into their own genome. This is typically done through the use of recombinant DNA technology, where a specific gene or genetic sequence of interest is isolated and then introduced into the mouse embryo. The resulting transgenic mice can then express the protein encoded by the foreign gene, allowing researchers to study its function in a living organism.

The process of creating transgenic mice usually involves microinjecting the exogenous DNA into the pronucleus of a fertilized egg, which is then implanted into a surrogate mother. The offspring that result from this procedure are screened for the presence of the foreign DNA, and those that carry the desired genetic modification are used to establish a transgenic mouse line.

Transgenic mice have been widely used in biomedical research to model human diseases, study gene function, and test new therapies. They provide a valuable tool for understanding complex biological processes and developing new treatments for a variety of medical conditions.

Eye burns typically refer to injuries or damage to the eyes caused by exposure to harmful substances, extreme temperatures, or radiation. This can result in a variety of symptoms, including redness, pain, tearing, swelling, and blurred vision.

Chemical eye burns can occur when the eyes come into contact with strong acids, alkalis, or other irritants. These substances can cause damage to the cornea, conjunctiva, and other structures of the eye. The severity of the burn will depend on the type and concentration of the chemical, as well as the length of time it was in contact with the eye.

Thermal eye burns can result from exposure to hot or cold temperatures, such as steam, flames, or extreme cold. These types of burns can cause damage to the surface of the eye and may require medical attention to prevent further complications.

Radiation eye burns can occur after exposure to high levels of ultraviolet (UV) light, such as from welding torches, sun lamps, or tanning beds. Prolonged exposure to these sources can cause damage to the cornea and other structures of the eye, leading to symptoms like pain, redness, and sensitivity to light.

If you experience symptoms of an eye burn, it is important to seek medical attention as soon as possible. Treatment may include flushing the eyes with water or saline solution, administering medication to relieve pain and inflammation, or in severe cases, surgery to repair damaged tissue.

A hindlimb, also known as a posterior limb, is one of the pair of extremities that are located distally to the trunk in tetrapods (four-legged vertebrates) and include mammals, birds, reptiles, and amphibians. In humans and other primates, hindlimbs are equivalent to the lower limbs, which consist of the thigh, leg, foot, and toes.

The primary function of hindlimbs is locomotion, allowing animals to move from one place to another. However, they also play a role in other activities such as balance, support, and communication. In humans, the hindlimbs are responsible for weight-bearing, standing, walking, running, and jumping.

In medical terminology, the term "hindlimb" is not commonly used to describe human anatomy. Instead, healthcare professionals use terms like lower limbs or lower extremities to refer to the same region of the body. However, in comparative anatomy and veterinary medicine, the term hindlimb is still widely used to describe the corresponding structures in non-human animals.

Intercellular signaling peptides and proteins are molecules that mediate communication and interaction between different cells in living organisms. They play crucial roles in various biological processes, including cell growth, differentiation, migration, and apoptosis (programmed cell death). These signals can be released into the extracellular space, where they bind to specific receptors on the target cell's surface, triggering intracellular signaling cascades that ultimately lead to a response.

Peptides are short chains of amino acids, while proteins are larger molecules made up of one or more polypeptide chains. Both can function as intercellular signaling molecules by acting as ligands for cell surface receptors or by being cleaved from larger precursor proteins and released into the extracellular space. Examples of intercellular signaling peptides and proteins include growth factors, cytokines, chemokines, hormones, neurotransmitters, and their respective receptors.

These molecules contribute to maintaining homeostasis within an organism by coordinating cellular activities across tissues and organs. Dysregulation of intercellular signaling pathways has been implicated in various diseases, such as cancer, autoimmune disorders, and neurodegenerative conditions. Therefore, understanding the mechanisms underlying intercellular signaling is essential for developing targeted therapies to treat these disorders.

Macular degeneration, also known as age-related macular degeneration (AMD), is a medical condition that affects the central part of the retina, called the macula. The macula is responsible for sharp, detailed vision, which is necessary for activities such as reading, driving, and recognizing faces.

In AMD, there is a breakdown or deterioration of the macula, leading to gradual loss of central vision. There are two main types of AMD: dry (atrophic) and wet (exudative). Dry AMD is more common and progresses more slowly, while wet AMD is less common but can cause rapid and severe vision loss if left untreated.

The exact causes of AMD are not fully understood, but risk factors include age, smoking, family history, high blood pressure, obesity, and exposure to sunlight. While there is no cure for AMD, treatments such as vitamin supplements, laser therapy, and medication injections can help slow its progression and reduce the risk of vision loss.

Matrix metalloproteinase 2 (MMP-2), also known as gelatinase A, is an enzyme that belongs to the matrix metalloproteinase family. MMPs are involved in the breakdown of extracellular matrix components, and MMP-2 is responsible for degrading type IV collagen, a major component of the basement membrane. This enzyme plays a crucial role in various physiological processes, including tissue remodeling, wound healing, and angiogenesis. However, its dysregulation has been implicated in several pathological conditions, such as cancer, arthritis, and cardiovascular diseases. MMP-2 is synthesized as an inactive proenzyme and requires activation by other proteases or chemical modifications before it can exert its proteolytic activity.

Intraocular injections are a type of medical procedure where medication is administered directly into the eye. This technique is often used to deliver drugs that treat various eye conditions, such as age-related macular degeneration, diabetic retinopathy, and endophthalmitis. The most common type of intraocular injection is an intravitreal injection, which involves injecting medication into the vitreous cavity, the space inside the eye filled with a clear gel-like substance called the vitreous humor. This procedure is typically performed by an ophthalmologist in a clinical setting and may be repeated at regular intervals depending on the condition being treated.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

Chemical burns are a type of tissue injury that results from exposure to strong acids, bases, or other corrosive chemicals. These substances can cause damage by reacting chemically with the skin or other tissues, leading to destruction of cells and potentially serious harm. The severity of a chemical burn depends on several factors, including the type and concentration of the chemical, the duration of exposure, and the amount of body surface area affected.

Chemical burns can occur through direct contact with the skin or eyes, inhalation of toxic fumes, or ingestion of harmful substances. Symptoms may include redness, pain, blistering, swelling, and irritation at the site of contact. In severe cases, chemical burns can lead to scarring, disability, or even death.

Immediate medical attention is required for chemical burns, as they can continue to cause damage until the source of the injury is removed, and appropriate first aid measures are taken. Treatment typically involves thorough cleaning and irrigation of the affected area, followed by administration of pain medication and other supportive care as needed. In some cases, skin grafting or other surgical interventions may be required to promote healing and minimize scarring.

Small interfering RNA (siRNA) is a type of short, double-stranded RNA molecule that plays a role in the RNA interference (RNAi) pathway. The RNAi pathway is a natural cellular process that regulates gene expression by targeting and destroying specific messenger RNA (mRNA) molecules, thereby preventing the translation of those mRNAs into proteins.

SiRNAs are typically 20-25 base pairs in length and are generated from longer double-stranded RNA precursors called hairpin RNAs or dsRNAs by an enzyme called Dicer. Once generated, siRNAs associate with a protein complex called the RNA-induced silencing complex (RISC), which uses one strand of the siRNA (the guide strand) to recognize and bind to complementary sequences in the target mRNA. The RISC then cleaves the target mRNA, leading to its degradation and the inhibition of protein synthesis.

SiRNAs have emerged as a powerful tool for studying gene function and have shown promise as therapeutic agents for a variety of diseases, including viral infections, cancer, and genetic disorders. However, their use as therapeutics is still in the early stages of development, and there are challenges associated with delivering siRNAs to specific cells and tissues in the body.

Sprague-Dawley rats are a strain of albino laboratory rats that are widely used in scientific research. They were first developed by researchers H.H. Sprague and R.C. Dawley in the early 20th century, and have since become one of the most commonly used rat strains in biomedical research due to their relatively large size, ease of handling, and consistent genetic background.

Sprague-Dawley rats are outbred, which means that they are genetically diverse and do not suffer from the same limitations as inbred strains, which can have reduced fertility and increased susceptibility to certain diseases. They are also characterized by their docile nature and low levels of aggression, making them easier to handle and study than some other rat strains.

These rats are used in a wide variety of research areas, including toxicology, pharmacology, nutrition, cancer, and behavioral studies. Because they are genetically diverse, Sprague-Dawley rats can be used to model a range of human diseases and conditions, making them an important tool in the development of new drugs and therapies.

Apoptosis is a programmed and controlled cell death process that occurs in multicellular organisms. It is a natural process that helps maintain tissue homeostasis by eliminating damaged, infected, or unwanted cells. During apoptosis, the cell undergoes a series of morphological changes, including cell shrinkage, chromatin condensation, and fragmentation into membrane-bound vesicles called apoptotic bodies. These bodies are then recognized and engulfed by neighboring cells or phagocytic cells, preventing an inflammatory response. Apoptosis is regulated by a complex network of intracellular signaling pathways that involve proteins such as caspases, Bcl-2 family members, and inhibitors of apoptosis (IAPs).

A peptide fragment is a short chain of amino acids that is derived from a larger peptide or protein through various biological or chemical processes. These fragments can result from the natural breakdown of proteins in the body during regular physiological processes, such as digestion, or they can be produced experimentally in a laboratory setting for research or therapeutic purposes.

Peptide fragments are often used in research to map the structure and function of larger peptides and proteins, as well as to study their interactions with other molecules. In some cases, peptide fragments may also have biological activity of their own and can be developed into drugs or diagnostic tools. For example, certain peptide fragments derived from hormones or neurotransmitters may bind to receptors in the body and mimic or block the effects of the full-length molecule.

Gene expression is the process by which the information encoded in a gene is used to synthesize a functional gene product, such as a protein or RNA molecule. This process involves several steps: transcription, RNA processing, and translation. During transcription, the genetic information in DNA is copied into a complementary RNA molecule, known as messenger RNA (mRNA). The mRNA then undergoes RNA processing, which includes adding a cap and tail to the mRNA and splicing out non-coding regions called introns. The resulting mature mRNA is then translated into a protein on ribosomes in the cytoplasm through the process of translation.

The regulation of gene expression is a complex and highly controlled process that allows cells to respond to changes in their environment, such as growth factors, hormones, and stress signals. This regulation can occur at various stages of gene expression, including transcriptional activation or repression, RNA processing, mRNA stability, and translation. Dysregulation of gene expression has been implicated in many diseases, including cancer, genetic disorders, and neurological conditions.

Enzyme inhibitors are substances that bind to an enzyme and decrease its activity, preventing it from catalyzing a chemical reaction in the body. They can work by several mechanisms, including blocking the active site where the substrate binds, or binding to another site on the enzyme to change its shape and prevent substrate binding. Enzyme inhibitors are often used as drugs to treat various medical conditions, such as high blood pressure, abnormal heart rhythms, and bacterial infections. They can also be found naturally in some foods and plants, and can be used in research to understand enzyme function and regulation.

Angiogenesis inducing agents are substances or drugs that stimulate the growth of new blood vessels, a process known as angiogenesis. This process is essential for the growth and development of tissues and organs in the body, including wound healing and the formation of blood vessels in the placenta during pregnancy. However, abnormal angiogenesis can also contribute to various diseases, such as cancer, diabetic retinopathy, and age-related macular degeneration.

Angiogenesis inducing agents are being studied for their potential therapeutic benefits in a variety of medical conditions. For example, they may be used to promote wound healing or tissue repair after injury or surgery. In cancer treatment, angiogenesis inhibitors are often used to block the growth of new blood vessels and prevent tumors from growing and spreading. However, angiogenesis inducing agents can have the opposite effect and may potentially be used to enhance the delivery of drugs to tumors or improve the effectiveness of other cancer treatments.

Examples of angiogenesis inducing agents include certain growth factors, such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF). These substances can be administered as drugs to stimulate angiogenesis in specific contexts. Other substances, such as hypoxia-inducible factors (HIFs) and prostaglandins, can also induce angiogenesis under certain conditions.

'Gene expression regulation' refers to the processes that control whether, when, and where a particular gene is expressed, meaning the production of a specific protein or functional RNA encoded by that gene. This complex mechanism can be influenced by various factors such as transcription factors, chromatin remodeling, DNA methylation, non-coding RNAs, and post-transcriptional modifications, among others. Proper regulation of gene expression is crucial for normal cellular function, development, and maintaining homeostasis in living organisms. Dysregulation of gene expression can lead to various diseases, including cancer and genetic disorders.

Signal transduction is the process by which a cell converts an extracellular signal, such as a hormone or neurotransmitter, into an intracellular response. This involves a series of molecular events that transmit the signal from the cell surface to the interior of the cell, ultimately resulting in changes in gene expression, protein activity, or metabolism.

The process typically begins with the binding of the extracellular signal to a receptor located on the cell membrane. This binding event activates the receptor, which then triggers a cascade of intracellular signaling molecules, such as second messengers, protein kinases, and ion channels. These molecules amplify and propagate the signal, ultimately leading to the activation or inhibition of specific cellular responses.

Signal transduction pathways are highly regulated and can be modulated by various factors, including other signaling molecules, post-translational modifications, and feedback mechanisms. Dysregulation of these pathways has been implicated in a variety of diseases, including cancer, diabetes, and neurological disorders.

Nestin contributes to laser choroidal and retinal neovascularization. Sofiane Miloudi,1 Maud Valensi,1 Mohamed El Sanharawi,1 ... In this work, we observed the retinal and choroidal localizations of nestin and its involvement in neovascularization after ... Grossniklaus HE, Kang SJ, Berglin L. Animal models of choroidal and retinal neovascularization. Prog Retin Eye Res. 2010; 29: ... Purpose: Choroidal and retinal neovascularization plays an essential role in various ocular diseases. In this study, we ...
To investigate the mechanism of sodium tanshinone IIA sulfonate inhibiting hypoxia induced retinal neovascularization in rats. ... Sodium tanshinone IIA sulfonate, hypoxia, retinal neovascularization, hyperplasia. The formation of retinal neovascularization ... Retinal ischemia-hypoxic eye disease has become a killer to deprive the light of the people. Retinal neovascularization is a ... microRNA‐9 inhibits retinal neovascularization in rats with diabetic retinopathy by targeting vascular endothelial growth ...
Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization. ... Opticin also accelerated regression of established retinal neovascularization, though the effect at 18 h was less than that of ... Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization ... Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization. ...
Thickness Measurements of Serous Retinal Detachment With Choroidal Neovascularization S. Ozawa; K. Ishikawa; Y. Ito; M. Kikuchi ... Thickness Measurements of Serous Retinal Detachment With Choroidal Neovascularization You will receive an email whenever this ... Thickness Measurements of Serous Retinal Detachment With Choroidal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2007;48(13 ... Invest Ophthalmol Vis Sci2005;46: E-Abstract 1550) The purpose of this study was to compare the thickness of serous retinal ...
Neovascularization, Retinal. On-line free medical diagnosis assistant. Ranked list of possible diseases from either several ...
Vitreous: An inhibitor of retinal extract-induced neovascularization. G. A. Lutty, D. C. Thompson, J. Y. Gallup, R. J. Mello, A ... Vitreous: An inhibitor of retinal extract-induced neovascularization. / Lutty, G. A.; Thompson, D. C.; Gallup, J. Y. et al. In ... Dive into the research topics of Vitreous: An inhibitor of retinal extract-induced neovascularization. Together they form a ... Vitreous : An inhibitor of retinal extract-induced neovascularization. In: Investigative Ophthalmology and Visual Science. 1983 ...
Branch Retinal Vein Occlusion With Neovascularization - Avastin. *Branch Retinal Vein Occlusion with Neovascularization - ... Central Retinal Vein Occlusion with Neovascularization - Avastin. *Central Retinal Vein Occlusion with Neovascularization - ... Branch Retinal Vein Occlusion With Neovascularization - Avastin. *Branch Retinal Vein Occlusion with Neovascularization - ... Central Retinal Vein Occlusion with Neovascularization - Avastin. *Central Retinal Vein Occlusion with Neovascularization - ...
Oeller described for the first time the presence of anastomoses between the retinal and choroidal circulations in eyes with ... Dilated retinal vessels may perfuse and drain the intraretinal neovascularization and form retino-retinal anastomoses (RRA)(9). ... In 1992, Hartnett et al.(7) described nine cases of retinal neovascularization, to which they referred as "deep retinal ... Neovascular Phenotypes: Retinal Angiomatous Proliferation (RAP) or Type 3 Neovascularization Authors:. Rufino Silva MD, PhD. ...
This was accompanied by retinal swelling and the appearance of cystoid spaces in both inner and ONLs of R91W;Nrl−/− mice ... Recently, we generated R91W;Nrl−/− double-mutant mice, which display a well-ordered all-cone retina with normal retinal ... mice to blue light not only induces cone cell death but also disrupts the inner blood-retinal barrier. Macular edema in humans ... Targeting Hif1a rescues cone degeneration and prevents subretinal neovascularization in a model of chronic hypoxia *Maya Barben ...
Development of a new mouse model of branch retinal vein occlusion and retinal neovascularization. / Zhang, Han; Sonoda, Koh Hei ... N2 - Purpose: Retinal neovascularization (NV) is associated with various disorders, such as retinal vein occlusion, diabetic ... AB - Purpose: Retinal neovascularization (NV) is associated with various disorders, such as retinal vein occlusion, diabetic ... Development of a new mouse model of branch retinal vein occlusion and retinal neovascularization. In: Japanese Journal of ...
Promoting effect of Toll like receptor 4 on oxygen-induced retinal neovascularization and its mechanism. October 9, 2019 ... TLR4 promotes retinal neovascularization probably by activating specific signaling pathways downstream of microglia cells and ... This study aimed to investigate the mechanism of TLR4 in oxygen induced retinal neovascularization in mice. ... Toll like receptor 4; Retinal neovascularization; angiogenesis; Ischemia/pathology; Neuroglia/metabolism; Disease models, ...
Tran KH, Ilsen PF (August 2007). "Peripheral retinal neovascularization in talc retinopathy". Optometry. 78 (8): 409-414. doi: ... Related retinal vasculature conditions include central retinal artery occlusion, central retinal vein occlusion and ... Cocaine is associated with retinal toxicity mainly through its negative impacts on the retinal vasculature. Cocaine use causes ... Hayreh SS (2014-12-08). "Retinal Survival Time and Visual Outcome in Central Retinal Artery Occlusion". Ocular Vascular ...
Retinal hemorrhages. 0. 0 (0-5.2). 2. 1.9 (0.2-7.5). Retinal neovascularization. 0. 0 (0-5.2). 1. 1 (0-5.9). ... Novel Retinal Lesion in Ebola Survivors, Sierra Leone, 2016 Paul J. Steptoe. , Janet T. Scott, Julia M. Baxter, Craig K. Parkes ... Geographic retinal darkening and variants. 16. 19.5 (10.7-31.2). 13. 12.4 (6.2-21.4). ... Novel Retinal Lesion in Ebola Survivors, Sierra Leone, 2016. ... Retinal tears. 1. 1.2 (0-7.5). 1. 1 (0-5.9). Retinal detachment ...
330 Results for Retinal Neovascularization near Ashburn, VA 20147 Sort: Recommended. Recommended Distance Rating: High to Low ...
Explore more about Retinal Neovascularization Epidemiology at: Retinal Neovascularization Epidemiology Insights. Retinal ... Retinal Neovascularization Market The Retinal Neovascularization market outlook of the report helps to build a detailed ... Retinal Neovascularization: An Overview. Retinal neovascularization refers to new abnormal blood vessel growth in your retina, ... Retinal Neovascularization Epidemiology The Retinal Neovascularization epidemiology section provides insights into the ...
Specifically, it is the second most common cause of blindness from retinal vascular disease after diabetic retinopathy. ... Retinal vein occlusion (RVO) is a common vascular disorder of the retina and one of the most common causes of vision loss ... Neovascularization can result in neovascular glaucoma, vitreous hemorrhage, and, in late or severe cases, retinal detachment. ... A: Central retinal vein occlusion (CRVO). B: Hemiretinal retinal vein occlusion (HRVO). C: Branch retinal vein occlusion (CRVO ...
... clinical conditions associated with choroidal neovascularization, clinical trials related to choroidal neovascularization in ... The book includes all aspects of choroidal neovascularization (CNV). It includes sections on basics, ... Pachychoroid related choroidal neovascularization. *Retinal dystrophy related choroidal neovascularization. *Stem cells in age- ... Inflammatory Choroidal Neovascularization *Alvaro Olate-Perez, Carolina Bernal-Morales, Aina Moll-Udina, Alfredo Adan, Javier ...
Choroidal Neovascularization / classification * Choroidal Neovascularization / diagnosis* * Choroidal Neovascularization / ... Conclusions: The presence of increased SRT thickness and volume on OCT, and to a lesser extent increased neurosensory retinal ... The detection of stronger correlations between retinal anatomy and visual acuity is likely to require the use of more advanced ... Purpose: To investigate the relationship between optical coherence tomography (OCT)-derived measurements of retinal morphology ...
... the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub-retinal ... Choroidal neovascularization (CNV) is a major cause of visual loss. ... Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina. 2008 Feb. 28 (2):201-11. [QxMD ... encoded search term (Choroidal Neovascularization (CNV)) and Choroidal Neovascularization (CNV) What to Read Next on Medscape ...
CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH RETINAL PIGMENT EPITHELIAL TEAR IMAGED BY OPT CHOROIDAL NEOVASCULARIZATION ... To report a patient presenting a retinal pigment epithelial tear in which optical coherence tomography angiography enabled the ... The reported case suggests the applicability of optical coherence tomography angiography in patients in whom retinal pigment ... Optical coherence tomography showed a retinal pigment epithelial tear with subretinal fluid. However, there was no clear ...
Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect. November ... Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect. ... The retinal NV areas assessed by isolectin B4 have been bigger than these assessed by FITC-dextran, however the retinal ... as a technique of demonstrating retinal neovascularization (NV) and avascular areas in oxygen-induced retinopathy (OIR) mice. ...
rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to ... rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to ... rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to ... rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to ...
Five-year real-world outcomes of occult and classic choroidal neovascularization: data from the Fight Retinal Blindness! ... Five-year real-world outcomes of occult and classic choroidal neovascularization: data from the Fight Retinal Blindness! ... Five-year real-world outcomes of occult and classic choroidal neovascularization : data from the Fight Retinal Blindness! ... title = "Five-year real-world outcomes of occult and classic choroidal neovascularization: data from the Fight Retinal ...
A branch retinal artery occlusion (BRAO) occurs when one of these branches of the arterial supply to the retina becomes ... The central retinal artery, a branch of the ophthalmic artery, enters the eye through the optic disc and divides into multiple ... Ocular neovascularization in eyes with a central retinal artery occlusion or a branch retinal artery occlusion. Clin Ophthalmol ... Retinal neovascularization after branch retinal arterial obstruction. Am J Ophthalmol. 1987 Sep 15. 104(3):294-6. [QxMD MEDLINE ...
Retinal Neovascularization ... View other providers who treat Retinal Detachment and Retinal ... View other providers who treat Repair of Retinal Detachment or Retinal Tear ... Repair of Retinal Detachment or Retinal Tear ...
Retinal And Choroidal Tumors * Retinal Degeneration * Retinal Detachment * Retinal Neovascularization * Retinal Vascular ...
Hydrogen sulfide contributes to retinal neovascularization in ischemia-induced retinopathy. Investigative Ophthalmology & ...
Retinal hemorrhage after photodynamic therapy in patients with subfoveal choroidal neovascularizations caused by age-related ... Central retinal thickness was measured at the foveola (between the retinal inner surface and retinal pigment epithelium) by OCT ... central retinal thickness; BCVA, best-corrected visual acuity; CNV, choroidal neovascularization; PCV, polypoidal choroidal ... Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in ...
... neovascularization of uveal and retinal tissues; congenital anomalies; and anemia.. Results. Twenty cases, fourteen dogs and ... Elsevier, Edinburgh.). Hyphema may be less commonly caused by tearing of retinal vasculature that occurs during retinal ... Vertical section of this globe shows diffuse retinal detachment and hemorrhage that occupies sub-retinal space, anterior and ... Vertical section of this globe shows diffuse retinal detachment and hemorrhage that occupies sub-retinal space, anterior and ...
  • Now, let's talk about why this condition occurs and how you may decrease the risk of a branch retinal vein occlusion in your other eye. (eyeknowmore.com)
  • While diabetes itself is not a risk factor for branch retinal vein occlusion, it can contribute to hardening of the arteries. (eyeknowmore.com)
  • There are a number of uncommon causes of this condition that make up an extremely small minority of branch retinal vein occlusion. (eyeknowmore.com)
  • Purpose: Retinal neovascularization (NV) is associated with various disorders, such as retinal vein occlusion, diabetic retinopathy, and retinopathy of prematurity, and often causes severe loss of vision. (elsevierpure.com)
  • Saturday night retinopathy is a condition that is due to central retinal or ophthalmic artery occlusion. (wikipedia.org)
  • This orbital compression will result in ophthalmic and central retinal artery occlusion which lead to ischemia in the inner retina and the patient may experience sudden unilateral blindness and eye pain. (wikipedia.org)
  • Retinal vein occlusion (RVO) is a common vascular disorder of the retina and one of the most common causes of vision loss worldwide. (medscape.com)
  • Occlusion of the central retinal vein at the level of the optic nerve is referred to as central retinal vein occlusion (CRVO). (medscape.com)
  • Obstruction at any more distal branch of the retinal vein is referred to as branch retinal vein occlusion (BRVO). (medscape.com)
  • A branch retinal artery occlusion (BRAO) occurs when one of these branches of the arterial supply to the retina becomes occluded. (medscape.com)
  • Color fundus photo of right eye with inferior branch retinal artery occlusion from a platelet-fibrin embolus. (medscape.com)
  • One study found that acute coronary syndrome occurred 1.72 times more often in patients with retinal artery occlusion than in controls. (medscape.com)
  • [ 16 ] Over a similar period, another study showed a 20% incidence of stroke in patients with retinal artery occlusion. (medscape.com)
  • a complication in near-sighted people where new blood vessels can grow in the back of the eye) and to treat macular edema after retinal vein occlusion (an eye disease caused by blockage of blood flow from the eye that leads to blurry vision and vision loss). (medlineplus.gov)
  • ABSTRACT To investigate the possible relationship between hyperhomocysteinaemia and retinal vascular occlusion, we measured plasma homocysteine levels in 25 patients with a history of retinal vascular occlu- sion in the previous 2 years and in a control group of 24. (who.int)
  • Most of the patients had branch retinal vein occlusion associated with recent onset of occlusion. (who.int)
  • Factors such as emotional status and associated systemic disease may play a role in predisposition of retinal vascular occlusion, so more-precise studies are needed to determine the possible risk factors of hyperhomocysteinaemia in retinal vascular occlusion. (who.int)
  • Although retinal vascular occlusion, glaucoma, uvei- the relationship between hyperhomocys- tis or intraocular surgery/trauma. (who.int)
  • BRVO (macular or main branch) or central and central retinal vein occlusion (CRVO) retinal artery occlusion. (who.int)
  • Considering the various uncertainties plasma samples were packed in an icebox regarding the many possible risk factors and sent to the Pars Laboratory, Tehran to for retinal vascular occlusion, this study measure plasma homocysteine levels. (who.int)
  • Central retinal vein occlusion is a blockage of the central retinal vein by a thrombus. (msdmanuals.com)
  • Occlusion may affect a branch of the retinal vein or the central retinal vein. (msdmanuals.com)
  • Neovascularization (abnormal new vessel formation) of the retina or iris (rubeosis iridis) occurs in about 16% of patients with central retinal vein occlusion and can result in secondary (neovascular) glaucoma, which can occur weeks to months after occlusion. (msdmanuals.com)
  • Retinal artery occlusion causes catastroph- embolysis, and there are only 2 reports on ic, sudden visual loss. (who.int)
  • More than 90% of eyes with successful use of Reynard and Hanscom's central retinal artery occlusion (CRAO) method [ 4 ], with some modifications, for have a sudden, painless decrease in visual the treatment of retinal artery occlusion. (who.int)
  • Involvement of the subretinal space with localized neurosensory retina detachment, edema and retinal hemorrhages at the edges may already be observed in colour fundus photography. (amdbook.org)
  • Neovascularization in the posterior eye can lead to vitreous hemorrhage and retinal detachment. (medscape.com)
  • Wet AMD is characterized by choroidal neovascularization (CNV) and the subsequent development of hemorrhage, exudation, scarring or retinal detachment. (spandidos-publications.com)
  • Coats disease is characterized by the presence of vascular dilatations (retinal telangiectasia), including ectatic arterioles, microaneurysms, venous dilations (phlebectasias), and fusiform capillary dilatations, which are frequently associated with exudative retinal detachment. (aao.org)
  • The clinical findings vary widely, ranging from mild retinal vascular abnormalities and minimal exudation to extensive areas of retinal telangiectasia associated with massive leakage and exudative retinal detachment. (aao.org)
  • Vitrectomy can restore vision in certain patients with recent traction retinal detachment and/or vitreous hemorrhage. (cdc.gov)
  • Retinal pigment epithelial (RPE) tear is an infrequent complication of pigment epithelial detachment in the elderly, and occurs either spontaneously or after laser photocoagulation. (ijo.in)
  • A CHOROID neovascularization characterized by serosanguineous retinal pigment epithelial detachment and leakage of serous exudate sometimes associated with aneurysmal polypoidal lesions. (bvsalud.org)
  • We have published a computer program which can analyze the optical coherence tomographic (OCT) images of the retina and determine the retinal thickness manually. (arvojournals.org)
  • Six radial scans of 6 mm length were obtained with the Fast Macular Thickness Map protocol of the Stratus OCT. The SRD thickness within the 3 mm diameter circle centered on the fovea was obtained by subtracting the thickness of the neurosensory retina from the distance from the inner surface of the retina to the retinal pigment epithelium. (arvojournals.org)
  • The modified assay is described in detail and used to demonstrate for the first time the inhibition by adult bovine vitreous of neovascularization induced by extracts of adult bovine retina. (johnshopkins.edu)
  • The results are consistent with the hypothesis that antiangiogenic substance(s) in vitreous and angiogenic components from retina may act as natural antagonists in controlling the process of retinal neovascularization. (johnshopkins.edu)
  • A blockage of the retinal veins can cause a decrease in the amount of blood flow to the retina. (eyeknowmore.com)
  • Un bloqueo de las venas retinianas puede causar una disminución en la cantidad de flujo sanguíneo a la retina. (eyeknowmore.com)
  • (9) who coined the term retinal angiomatous proliferation (RAP) when in 2001 the authors described chorioretinal anastomoses as a neovascular proliferation originating deeply in the retina. (amdbook.org)
  • described chorioretinal anastomosis as neovascular proliferation with origin in the retina, and proposed the designation of RAP - retinal angiomatous proliferation (9) . (amdbook.org)
  • (14) escribed 5 cases of RAP with the neovascular complex originating in the choroid instead of the retina, and proposed that RAP should be called type 3 neovascularization instead. (amdbook.org)
  • Usually, a clear RRA can be seen, with a perfusing retina arteriole and draining venule communicating within the core of the subretinal neovascularization (Figure 1). (amdbook.org)
  • Recently, we generated R91W;Nrl −/− double-mutant mice, which display a well-ordered all-cone retina with normal retinal vasculature and a strong photopic function that generates useful vision. (nature.com)
  • This significantly reduces the blood flow to retina and eventually lead to retinal ischemia. (wikipedia.org)
  • Retinal neovascularization refers to new abnormal blood vessel growth in your retina, the part of your eye that contains light-sensing cells. (thealphareporter.com)
  • In both ischemic and nonischemic CRVO, blockage of the retinal vein occurs, but the nonischemic type is able to maintain better relative blood flow to the retina through collaterals. (medscape.com)
  • The central retinal artery, a branch of the ophthalmic artery, enters the eye through the optic disc and divides into multiple branches to perfuse the inner layers of the retina. (medscape.com)
  • 1 While the fundus findings may be predominantly located at the central retina, in the vast majority of MDs there is psychophysical, electrophysiological or histopathological evidence of more widespread, generalised retinal involvement. (bmj.com)
  • He received fellowship training in Retinal Vascular Diseases at the Wilmer Eye Institute of the Johns Hopkins University and fellowship training in Diseases and Surgery of the Retina and Vitreous at Barnes Hospital/Retina Consultants, Ltd. of Washington University. (medstarhealth.org)
  • Specifically, it is the second most common cause of blindness from retinal vascular disease after diabetic retinopathy . (medscape.com)
  • Activation of the PERK/eIF2α/ATF4 signaling pathway has been reported in numerous retinal degenerative diseases including AMD ( 16 ), glaucomatous retinopathy ( 19 ) and diabetic retinopathy ( 20 ). (spandidos-publications.com)
  • For milder cases of lipid exudation, additional considerations are diabetic retinopathy, BRVO, juxtafoveal retinal telangiectasia, and radiation retinopathy. (aao.org)
  • Laser treatments or intravitreal injections could be a thing of the past when it comes to treating proliferative diabetic retinopathy (PDR) if findings from new research into retinal neovascularization are any indication. (aoa.org)
  • PDR, the most advanced stage of diabetic retinopathy , occurs with retinal neovascularization that can result in serious vision loss or blindness. (aoa.org)
  • Catching diabetic retinopathy early enough is critical to preserving vision, but this study hints at going beyond early detection-the possibility of using self-administered topical eye drops or systemic drugs to hedge against neovascularization in the first place. (aoa.org)
  • Patients were classified into 3 clusion is a major cause of retinal vascular major categories of retinal vascular occlu- disease, second only to diabetic retinopathy sion based on their first episode: CRVO, [ 3 ]. (who.int)
  • Visual morbidity and blindness in RVO result from macular edema, retinal hemorrhage, macular ischemia, and neovascular glaucoma. (medscape.com)
  • Vitreous hemorrhage may result from retinal neovascularization. (msdmanuals.com)
  • RVO is further subdivided into nonischemic and ischemic types, according to the amount of retinal capillary ischemia seen by the ophthalmologist on fluorescein angiography. (medscape.com)
  • Such a distinction is relevant to the clinician, since two thirds of patients with the ischemic type develop the dreaded complications of macular edema, macular ischemia, and neovascularization that lead to blindness. (medscape.com)
  • Finally, the ischemia reperfusion (I/R) injury model was used in C57BL/6J mice to induce retinal inflammation and investigate the effects of caffeine treatment. (frontiersin.org)
  • They found that hCRP promotes ischemia-induced retinal neovascularization in a rat model of oxygen-induced retinopathy. (portlandpress.com)
  • Choroidal and retinal neovascularization plays an essential role in various ocular diseases. (molvis.org)
  • The formation of retinal neovascularization is one of the serious complications of intraocular diseases. (ijpsonline.com)
  • In conclusion, these findings suggest that caffeine is a good candidate to counteract inflammation in retinal diseases. (frontiersin.org)
  • Metabolic syndrome (MetS) is associated with several degenerative diseases, including retinal degeneration. (molvis.org)
  • Author of more than 150 publications on retinal diseases and surgery, Dr. Elman is an Assistant Professor of Ophthalmology at the Johns Hopkins University School of Medicine. (medstarhealth.org)
  • Macular edema (hard lipid exudates and/or retinal thickening inside the temporalvascular arcades). (cdc.gov)
  • Human retinal pigment epithelial cells (ARPE-19) were exposed to lipopolysaccharide (LPS) with or without caffeine. (frontiersin.org)
  • The inciting factor in BRVO is often compression of the adjacent vein by atherosclerotic retinal arteries at the site of AV crossing, leading to turbulent flow and venous stasis. (medscape.com)
  • Genetic factors are im- oedema along obstructed retinal vein). (who.int)
  • Retinal vein oc- measured. (who.int)
  • These changes are typically diffuse if obstruction involves the central retinal vein and are limited to one quadrant if obstruction involves only a branch of the central retinal vein. (msdmanuals.com)
  • Central retinal vein occlusions rarely recur. (msdmanuals.com)
  • To investigate the relationship between optical coherence tomography (OCT)-derived measurements of retinal morphology and visual acuity in patients with neovascular age-related macular degeneration (AMD). (nih.gov)
  • OCT-derived measurements of retinal morphology and visual acuity. (nih.gov)
  • For occult lesions, 20% of the variation in visual acuity could be predicted by a multiple regression model that incorporated age and SRT volume, whereas, for minimally classic lesions, 62% of the variation in visual acuity could be predicted by a multiple regression model that incorporated age, total neurosensory retinal volume, and total SRT volume. (nih.gov)
  • The presence of increased SRT thickness and volume on OCT, and to a lesser extent increased neurosensory retinal thickness and volume, is associated with decreased visual acuity in neovascular AMD. (nih.gov)
  • The detection of stronger correlations between retinal anatomy and visual acuity is likely to require the use of more advanced imaging modalities. (nih.gov)
  • The CATT study involved 1185 participants with choroidal neovascularization secondary to AMD with a baseline visual acuity of 20/25 to 20/320.The mean visual acuity at baseline was 61 letters. (medscape.com)
  • 2-4 Data from open-label studies using optical coherence tomography (OCT)-guided re-treatment strategies have shown that improvements in best-corrected visual acuity (BCVA) and OCT-assessed central retinal thickness can be achieved with fewer ranibizumab injections than the fixed monthly dosing regimens used in studies such as MARINA and ANCHOR. (bmj.com)
  • Patients should be referred to an ophthalmologist promptly for unexplained visual symptoms, reduced corrected visual acuity, increased intraocular pressure, any retinal abnormalities, or any other ocular pathology that threatens vision. (cdc.gov)
  • As observed on angiography, the numbers of choroidal and retinal blood vessels were significantly increased (principally on the seventh day) after the laser impacts. (molvis.org)
  • Dilated retinal vessels may perfuse and drain the intraretinal neovascularization and form retino-retinal anastomoses (RRA) (9) . (amdbook.org)
  • After entering the systemic circulation, it will deposit in the retinal blood vessels and undergo reaction which lead to focal narrowing of retinal vessels. (wikipedia.org)
  • A dependable and efficient methodology is required to ship agent that may support the in vivo imaging of retinal vessels. (teitell-lab.com)
  • Totally different concentrations of FITC-dextran have been used to match the efficacy of this agent in perfusing the retinal vessels. (teitell-lab.com)
  • Fluorescein angiography and electroretinography were used to compare the extent of fluorescein leakage from retinal vessels and retinal function, respectively. (edu.au)
  • After a single rAAV.sFlt-1 injection, sFlt-1 protein levels were upregulated, and there was a reduction in fluorescein leakage from the retinal vessels and an improvement in retinal function. (edu.au)
  • Light microscopy demonstrated retinal morphology preservation, with fewer aberrant vessels invading the outer nuclear layer of rAAV.sFlt-1-injected eyes. (edu.au)
  • In 90% of cases, BRAOs involve the temporal retinal vessels. (medscape.com)
  • Whether the temporal retinal vessels are affected more often or whether the nasal retinal vessel occlusions are more often undetected is unclear. (medscape.com)
  • Retinal neovascularisation is when new, fragile blood vessels grow, uncontrolled at the back of the eye. (europa.eu)
  • Published online in the journal Diabetes , the Massachusetts Eye and Ear Infirmary study identifies a particular transcription factor commonly found in abnormal retinal blood vessels that can be inhibited to achieve a 50% reduction in retinopathy. (aoa.org)
  • Leakage may not be revealed by FA, probably because fibrin from retinal exudates cannot be impregnated with fluorescein, opposing to what occurs with ICG-A (16) . (amdbook.org)
  • We generated and purified recombinant human opticin and investigated its impact on the development and regression of pathological retinal neovascularization following intravitreal administration in murine oxygen-induced retinopathy. (ucl.ac.uk)
  • In oxygen-induced retinopathy, intravitreal administration of human recombinant opticin protected against the development of retinal neovascularization to similar extent as aflibercept, which targets VEGF. (ucl.ac.uk)
  • Studies showed that Toll like receptors (TLRs) play an important role in the development of retinal angiogenesis.However, the effect and mechanism of TLR4 affecting angiogenesis in oxygen induced retinopathy (OIR) had not been clarified yet. (cjeo-journal.org)
  • This study aimed to investigate the mechanism of TLR4 in oxygen induced retinal neovascularization in mice. (cjeo-journal.org)
  • The intention of the current examine was to guage retro-orbital (RO) injection of fluorescein-labeled isothiocyanate dextran (FITC-dextran) as a technique of demonstrating retinal neovascularization (NV) and avascular areas in oxygen-induced retinopathy (OIR) mice. (teitell-lab.com)
  • To induce neovascularization in these mice, we use a model called Oxygen-induced Retinopathy (OIR). (europa.eu)
  • The present study investigated the effects of GSK2606414 on proliferation, apoptosis, and the expression of activating transcription factor 4 (ATF4), CCAAT/enhancer‑binding protein homologous protein (CHOP) and vascular endothelial growth factor (VEGF) in human retinal pigment epithelial (RPE) cells under endoplasmic reticulum (ER) stress. (spandidos-publications.com)
  • About 15% of AMD patients switch to the wet form, characterized by choroidal neovascularization. (frontiersin.org)
  • The fluorescein angiography (FA) of the intraretinal neovascular complex shows a focal hyperfluorescent area in front of the retinal pigment epithelium (RPE), mimicking classic choroidal or, more frequently, occult neovascularization. (amdbook.org)
  • The ischemic type is associated with marked decreased vision, as ischemic CRVO predisposes to anterior neovascularization called rubeosis irides, which leads to high-pressure neovascular glaucoma. (medscape.com)
  • However, there was no clear evidence of CNV on fluorescein angiography or OCT. Optical coherence tomography angiography confirmed the presence of an active CNV by the visualization of the neovascular network in the region corresponding to the scrolled up retinal pigment epithelium . (bvsalud.org)
  • Singerman LJ, Masonson H, Patel M, Adamis AP, Buggage R, Cunningham E. Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial. (medscape.com)
  • When we place mice lacking Hif1α, Hif2α or both (from their myeloid cells) in the chamber, we don't find any difference in the empty area or the formation of neovascular tufts when compared with normal mice (Figure 1B), meaning that Hif1α and Hif2α in myeloid cells are not essential for neovascularisation. (europa.eu)
  • Treatment of Coats disease generally consists of ablation with photocoagulation or cryotherapy, and, in severe cases, retinal reattachment surgery. (aao.org)
  • Retinal pigment epithelial (RPE) tear has been described to occur spontaneously, after laser photocoagulation and in recent times, after intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents. (ijo.in)
  • To report a patient presenting a retinal pigment epithelial tear in which optical coherence tomography angiography enabled the visualization of subfoveal choroidal neovascularization (CNV) not evidenced by the fluorescein angiography . (bvsalud.org)
  • Photodynamic therapy (PDT) with verteporfin has been previously shown to be beneficial and safe as one of the standard therapies for subfoveal choroidal neovascularization (CNV). (dovepress.com)
  • The current methods of clinical treatment of retinal neovascularization include surgery and laser treatment. (ijpsonline.com)
  • We used Brown Norway rats, in which choroidal and retinal neovascularization was induced using intraocular laser impacts. (molvis.org)
  • A group of eyes was enucleated, and the retinal vasculature and morphology were studied by confocal and light microscopy. (edu.au)
  • The retinal morphology and ultrastructure of WNIN/GR-Ob and age-matched littermate lean rats were studied by microscopy and immunohistochemistry. (molvis.org)
  • Although angiography demonstrates the presence of retinal capillary nonperfusion, posterior segment neovascularization is unusual. (aao.org)
  • 0001), larger choroidal neovascularization area ( P = .002), and the presence of retinal pigment epithelium elevation ( P = .001). (medscape.com)
  • Purpose: To compare 5-year real-world outcomes of eyes with classic and occult choroidal neovascularization (CNV) treated with anti-vascular endothelial growth factor (anti-VEGF) injections. (edu.au)
  • The best-known activator of neovascularisation is a molecule called Vascular Endothelial Growth Factor (VEGF). (europa.eu)
  • There are drugs that can stop VEGF working, but these only slow the progression of sight loss, which means there are other factors which must also influence neovascularisation. (europa.eu)
  • 1 The widespread use of ranibizumab intravitreal injection for the treatment of this condition was based on results from the pivotal Phase III Minimally Classic/Occult Trial of the Anti-VEGF Antibody Ranibizumab in the Treatment of Neo-vas-cular AMD (MARINA) and Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularisation in AMD (ANCHOR) studies. (bmj.com)
  • This study aimed to evaluate the long-term effectiveness of intravitreal anti-vascular endothelial growth factor (VEGF) injections in the treatment of choroidal neovascularization (CNV) associated with angioid streaks. (hindawi.com)
  • Immunohistochemical analysis showed decreased levels of rhodopsin and postsynaptic density protein-95 (PSD-95) proteins and increased levels of glial fibrillary acidic protein (GFAP), vascular endothelial growth factor (VEGF), and calretinin in WNIN/GR-Ob rats compared with the age-matched lean controls, further supporting cellular stress/damage and retinal degeneration. (molvis.org)
  • Since the US Food and Drug Administration approval of ranibizumab in 2006, antivascular endothelial growth factor (VEGF) therapy for choroidal neovascularization (CNV) for age-related macular degeneration (AMD) has become standard therapy. (medscape.com)
  • Cite this: Anti-angiogenesis in Eyes With Choroidal Neovascularization - Medscape - Aug 14, 2008. (medscape.com)
  • E-Abstract 1550) The purpose of this study was to compare the thickness of serous retinal detachments (SRDs) in eyes with age-related macular degeneration (AMD) to those with polypoidal choroidal vasculopathy (PCV) using our program. (arvojournals.org)
  • The acute model of light-induced retinal degeneration uses short exposure to bright white light to study photoreceptor cell death leading to loss of vision. (nature.com)
  • Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration? (medscape.com)
  • Age-related macular degeneration (AMD) is a retinal degenerative disease, which causes progressive loss of central vision in the elderly ( 1 ). (spandidos-publications.com)
  • Neovascularisation is a feature of several conditions including diabetes and macular degeneration. (europa.eu)
  • Previously, we reported on progressive retinal degeneration in a spontaneous obese rat (WNIN/Ob) model. (molvis.org)
  • In this study, we investigated the additional effect of impaired glucose tolerance (IGT), an essential component of MetS, on retinal degeneration using the WNIN/GR-Ob rat model. (molvis.org)
  • WNIN/GR-Ob rats with added glucose intolerance developed retinal degeneration similar to the parent line WNIN/Ob. (molvis.org)
  • The severity of retinal degeneration was greater in WNIN/GR-Ob rats compared to WNIN/Ob, suggesting a possible role for IGT in this model. (molvis.org)
  • Hence, the WNIN/GR-Ob model could be a valuable tool for investigating the impact of MetS on retinal degeneration pathology. (molvis.org)
  • The reported case suggests the applicability of optical coherence tomography angiography in patients in whom retinal pigment epithelial tear is detected and associated CNV is suspected. (bvsalud.org)
  • If too much force is applied, it can cause a blockage of a branch of the retinal veins. (eyeknowmore.com)
  • Choroidal neovascularisation secondary to Best's disease in a 13-year-old boy treated by intravitreal bevacizumab. (medscape.com)
  • Currently, no specific treatment is deemed effective in treating Saturday Night retinopathy as the ischemic injury caused by prolonged compression by external forces is irreversibly dealt to the retinal vasculature. (wikipedia.org)
  • Wet AMD is characterized by new blood vessel growth, commonly known as choroidal neovascularization. (frontiersin.org)
  • Five-year real-world outcomes of occult and classic choroidal neovascularization: data from the Fight Retinal Blindness! (edu.au)
  • Confocal microscopy of isolectin-IB4-labeled retinal wholemounts showed more normal-appearing capillary beds in rAAV.sFlt-1-injected than in PBS-injected trVEGF029 mouse eyes. (edu.au)
  • Stage I - Intraretinal neovascularization. (amdbook.org)
  • We also investigated its effect on normal retinal vascular development and function, following intravitreal injection in neonatal mice, by histological examination and electroretinography. (ucl.ac.uk)
  • Intravitreal administration of human recombinant opticin in neonatal mice caused no detectable perturbation of subsequent retinal vascular development or function. (ucl.ac.uk)
  • From an ocular standpoint, and in the absence of subsequent retinal artery occlusions, vision usually stabilizes soon after the ischemic event. (medscape.com)
  • Figure 1: (A) Fundus photograph of the left eye showing the presence of a juxtafoveal retinal pigment epithelial (RPE) tear. (ijo.in)
  • Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization. (medscape.com)
  • Retinal whitening surrounding the occluded artery is noted. (medscape.com)
  • Also, total retinal thickness decreased between week 24 and year 1 by a mean of 26 μm ( P = .04), and by year 2, the mean decrease was 36 μm ( P = .02). (medscape.com)
  • In retinal images of a patient with sickle cell disease, PSR is characterized by a retinal lesion known as a sea fan neovascularization complex. (jhu.edu)
  • Indeed, when appropriate parameters are used for laser ray administration, the laser impacts break Bruch's membrane and induce subretinal neovascularization. (molvis.org)
  • A rare, long-term ophthalmic complication is neovascularization. (medscape.com)
  • [ 4 ] Breakdown of RPE/Bruchs membrane can allow choroidal neovascularization to develop as a late complication. (medscape.com)
  • 1 - 3 It is characterized by diffuse or cystic macular thickening with or without lipid exudation caused by breakdown of the inner and outer blood retinal barriers. (dovepress.com)
  • The study eye had not yet received treatment for active choroidal neovascularization, and patients received either ranibizumab ( Lucentis , Genentech) or bevacizumab ( Avastin , Genentech) in one of three dosing regimens. (medscape.com)
  • Optical coherence tomography showed a retinal pigment epithelial tear with subretinal fluid . (bvsalud.org)
  • DelveInsight's "Retinal Neovascularization Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Retinal Neovascularization, historical and forecasted epidemiology as well as the Retinal Neovascularization market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. (thealphareporter.com)
  • The Retinal Neovascularization epidemiology section provides insights into the historical and current Retinal Neovascularization patient pool and forecasted trends for seven individual major countries. (thealphareporter.com)
  • The Hopkins team is working to develop an automated algorithm for detecting sea fan neovascularization from ultra-widefield color fundus photographs. (jhu.edu)

No images available that match "retinal neovascularization"